Element Solutions (ESI) 10-Q 7 May 14 2014 Q1 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Mar. 31, 2014	2-May-14
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'Platform Specialty Products Corp	'
Document Type	'10-Q	'
Current Fiscal Year End Date	'--12-31	'
Entity Common Stock, Shares Outstanding	'	121,491,080
Amendment Flag	'false	'
Entity Central Index Key	'0001590714	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Filer Category	'Non-accelerated Filer	'
Entity Well-known Seasoned Issuer	'No	'
Document Period End Date	31-Mar-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Net sales	$183,726	$182,132
Cost of sales	99,504	88,818
Gross profit	84,222	93,314
Operating expenses:	'	'
Selling, technical, general and administrative	74,032	55,980
Research and development	6,198	5,952
Restructuring	0	1,606
Total operating expenses	80,230	63,538
Operating profit	3,992	29,776
Other (expense) income:	'	'
Interest, net	-7,742	-11,718
Other (expense) income, net	-89	3,587
	-7,831	-8,131
(Loss) income before income taxes, non-controlling interests and accrued payment-in-kind dividends on cumulative preferred shares	-3,839	21,645
Income tax provision	-2,109	-6,308
Net (loss) income	-5,948	15,337
Net income attributable to the non-controlling interests	-1,469	-89
Net (loss) income attributable to common shareholders	-7,417	15,248
Accrued payment-in-kind dividend on cumulative preferred shares	'	-11,794
Net (loss) income attributable to common shares	($7,417)	$3,454
Earnings (loss) per share	'	'
Basic (in Dollars per share)	($0.07)	'
Diluted (in Dollars per share)	($0.07)	'
Weighted average shares outstanding (In thousands)	'	'
Basic (in Shares)	107,160	'
Diluted (in Shares)	107,160	'

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Net (loss) income	($5,948)	$15,337
Other comprehensive (loss) income, before tax	'	'
Foreign currency translation adjustments	-9,276	-16,524
Unrealized (loss) gain on available for sale securities	-52	145
Derivative financial instruments revaluation	15	-780
Total other comprehensive loss, before tax	-9,313	-17,159
Income tax benefit on comprehensive loss	18	222
Other comprehensive loss, net of tax	-9,295	-16,937
Comprehensive income attributable to the non-controlling interests	-1,465	-57
Comprehensive loss attributable to common shareholders	($16,708)	($1,657)

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Assets	'	'
Cash & cash equivalents	$316,604	$123,040
Accounts receivable, net of allowance for doubtful accounts of $10,242 and $10,113 at March 31, 2014 and December 31, 2013, respectively	141,384	140,525
Inventories	79,870	89,618
Prepaid expenses & other current assets	21,347	30,056
Total current assets	559,205	383,239
Property, plant & equipment, net	135,743	139,670
Goodwill	1,001,748	1,002,886
Intangible assets, net	665,577	683,004
Other assets	31,957	33,089
Total assets	2,394,230	2,241,888
Liabilities & Stockholders' Equity	'	'
Accounts payable	54,230	56,156
Accrued salaries, wages and employee benefits	13,426	22,656
Current installments of long-term debt	7,911	7,958
Accrued income taxes payable	4,656	6,610
Accrued expenses and other current liabilities	26,903	26,040
Total current liabilities	107,126	119,420
Long-term debt	742,327	744,291
Long-term retirement benefits, less current portion	21,532	25,129
Long-term deferred income taxes	135,287	138,273
Long-term contingent consideration	47,800	34,800
Other long-term liabilities	36,127	30,387
Total liabilities	1,090,199	1,092,300
Redeemable 401(k) plan interest	'	20,972
Stockholders' Equity	'	'
Preferred shares (2,000,000 designated as Series A), 5,000,000 shares authorized, 2,000,000 shares issued and outstanding at March 31, 2014 and December 31, 2013, respectively	20	'
Common shares, $0.01 par value (effective January 23, 2014), 200,000,000 shares authorized, 120,239,236 and 103,571,941 shares issued and outstanding at March 31, 2014 and December 31, 2013, respectively	1,182	'
Additional paid-in capital	1,401,673	1,212,038
Accumulated deficit	-201,639	-194,222
Accumulated other comprehensive income	5,484	14,779
Total stockholders equity	1,206,720	1,032,595
Non-controlling interests	97,311	96,021
Total equity	1,304,031	1,128,616
Total liabilities, redeemable 401(k) plan interest and stockholders' equity	$2,394,230	$2,241,888

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified
Accounts receivable, allowance for doubtful accounts (in Dollars)	$10,242	$10,113
Preferred shares authorized	5,000,000	5,000,000
Preferred shares, shares issued	2,000,000	2,000,000
Preferred shares, shares outstanding	2,000,000	2,000,000
Common shares, par value (in Dollars per share)	$0.01	$0.01
Common shares authorized	200,000,000	200,000,000
Common shares issued	120,239,236	103,571,941
Common shares outstanding	120,239,236	103,571,941
Series A Preferred Stock [Member]	'	'
Preferred shares authorized	2,000,000	2,000,000

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:	'	'
Net (loss) income	($5,948)	$15,337
Adjustments to reconcile net (loss) income from operations to net cash flows provided by operating activities:	'	'
Depreciation and amortization	16,890	9,887
Non-cash fair value adjustment to contingent consideration	13,000	'
Manufacturer's profit in inventory adjustment	11,956	'
Other, net	-2,132	625
Changes in assets & liabilities, net of acquisitions:	'	'
Accounts receivable	-1,035	-4,328
Inventories	-1,886	-5,758
Accrued expenses	-7,945	7,179
Other assets and liabilities	-1,835	174
Net cash flows provided by operating activities	21,065	23,116
Cash flows from investing activities:	'	'
Capital expenditures, net	-2,025	-1,331
Acquisition of business, net	5,941	'
Other, net	-1,114	-1,290
Net cash flows provided by (used in) investing activities	2,802	-2,621
Cash flows from financing activities:	'	'
Repayments of borrowings	-2,013	-19,868
Proceeds from issuance of common stock, net	172,463	'
Other, net	-191	-156
Net cash flows provided by (used in) financing activities	170,259	-20,024
Effect of exchange rate changes on cash and cash equivalents	-562	-781
Net increase (decrease) in cash and cash equivalents	193,564	-310
Cash and cash equivalents at beginning of period	123,040	143,351
Cash and cash equivalents at end of period	$316,604	$143,041

Note_1_Basis_of_Presentation

Note 1 - Basis of Presentation	3 Months Ended
	Mar. 31, 2014
Disclosure Text Block [Abstract]	'
Business Description and Basis of Presentation [Text Block]	'
	1. BASIS OF PRESENTATION
	Platform Specialty Products Corporation and its subsidiaries (“Platform,” the “Company,” “we” or “us”) (formerly named Platform Acquisition Holdings Limited) is a global producer of high-technology specialty chemical products and provider of technical services and currently operates through its indirect subsidiary, MacDermid, Incorporated (“MacDermid” or the “Predecessor”).  Platform was originally incorporated with limited liability under the laws of the British Virgin Islands under the BVI Companies Act on April 23, 2013. Until its acquisition of MacDermid on October 31, 2013, the Company had neither engaged in any operations nor generated any income. As such, the Company was considered to be in the development stage as defined in FASB Accounting Standards Codification 915, or FASB ASC 915, “Development Stage Entities,” and was subject to the risks associated with activities of development stage companies. The Company selected December 31 as its fiscal year end.
	On October 31, 2013, Platform indirectly acquired substantially all of the equity of, MacDermid Holdings, LLC (“MacDermid Holdings”), which owned approximately 97% of MacDermid (the “MacDermid Acquisition”). As a result, Platform became a holding company for the MacDermid business.  We acquired the remaining 3% of MacDermid on March 4, 2014, pursuant to the terms of an Exchange Agreement, dated October 25, 2013, between us and the fiduciaries of the MacDermid, Incorporated Profit Sharing and Employee Savings Plan (the “MacDermid Savings Plan”).  Concurrently with the closing of the MacDermid Acquisition, we changed our name to Platform Specialty Products Corporation. On January 22, 2014, we changed our jurisdiction of incorporation from the British Virgin Islands to Delaware (the “Domestication”) and on January 23, 2014, our shares of common stock, par value $0.01 per share (“Common Stock”) began trading on the New York Stock Exchange (“NYSE”) under the ticker symbol “PAH”.
	The accompanying unaudited condensed consolidated interim financial statements and information included herein are for the Company as of March 31, 2014 and December 31, 2013 and for the period from January 1, 2014 through March 31, 2014 (the “Successor Period”), and for MacDermid for the period from January 1, 2013 through March 31, 2013 (the “Predecessor Period”), which preceeded the consummation of the MacDermid Acquisition.  These unaudited condensed consolidated interim financial statements and related information have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. These unaudited condensed consolidated interim financial statements reflect all adjustments that are, in the opinion of management, normal and recurring and necessary for a fair statement of the results for the interim period but are not necessarily indicative of the results of operations for the full fiscal year 2014 or any future period. The Condensed Consolidated Balance Sheet at December 31, 2013 has been derived from the audited financial statements as of that date, but does not include all of the information and footnotes required by GAAP for complete financial statements. These unaudited condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and the related notes thereto included in the Company’s latest Annual Report on Form 10-K for the fiscal year ended December 31, 2013, filed with the SEC on March 31, 2014.
	Out of period adjustment - During the period ended March 31, 2014, the Company identified a prior period adjustment totaling approximately $4 million related to foreign currency translation adjustments to goodwill, intangible assets and deferred tax liabilities which was corrected within the current quarter and had no impact to net income in 2013. Management has determined these out of period correcting adjustments are not material to the prior period financial statements and has therefore recorded them in the three months ended March 31, 2014.
	In March 2013, the Financial Accounting Standards Board (the “FASB”)  issued ASU No. 2013-05, “Foreign Currency Matters (Topic 830): Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity, (a consensus of the FASB Emerging Issues Task Force)” which resolves diversity in practice regarding the release of the cumulative translation adjustment into net income when a parent either sells a part or all of its investments in a foreign entity. In addition, the standard resolves diversity in practice for the treatment of business combinations achieved in stages involving a foreign entity. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2013. The adoption of this new ASU did not have a material impact on our consolidated financial position, results of operations or cash flows in the Successor Period.

Note_2_Acquisitions_of_Busines

Note 2 - Acquisitions of Businesses	3 Months Ended
	Mar. 31, 2014
Business Combinations [Abstract]	'
Business Combination Disclosure [Text Block]	'
	2.  ACQUISITIONS OF BUSINESSES
	MacDermid Acquisition
	On October 31, 2013, the Company completed the MacDermid Acquisition. The total consideration paid in connection with the MacDermid Acquisition and the acquisition of the approximately 3% of MacDermid equity interests (the “MacDermid Plan Shares”) not already held by MacDermid Holdings was approximately $1,800,000 (including the assumption of approximately $754,200 of indebtedness), plus (i) up to $100,000 of contingent consideration tied to achievement of EBITDA and stock trading price performance metrics over a seven-year period following the closing of the MacDermid Acquisition and (ii) an interest in certain MacDermid pending litigation. As a result of a favorable adjustment to the preliminary estimated working capital factored into the purchase price, the Company received a payment of approximately $8,540 in January 2014 which is reflected in “Acquisition of business, net” in the accompanying Condensed Consolidated Statements of Cash Flows.
	The fair value of contingent consideration was measured based on significant inputs not observable in the market, which are considered to be Level 3 inputs under the ASC 820 fair value hierarchy (see Note 10). Key assumptions included in the fair value calculation of the EBITDA related earnout include a discount rate of approximately 2% and expected future value of payments of $60,000 calculated using a probability weighted EBITDA assessment with higher probability associated with the Company achieving the maximum EBITDA targets. Key assumptions included in the fair value calculation of the stock price related earnout include the fair value of Common Stock and an assumption of volatility.  The stock price related earnout was calculated using a Monte Carlo simulation.  At the inception of the MacDermid Acquisition, the fair value of the contingent payments was $35,500. As of March 31, 2014 and December 31, 2013, the fair value of the contingent consideration was $47,800 and $34,800, respectively, which was included in “Other long-term liabilities” in the accompanying Condensed Consolidated Balance Sheets. The $13,000 increase in fair value during the three months ended March 31, 2014, which is recorded in “Selling, technical, general and administrative expenses” in the accompanying Condensed Consolidated Statements of Operations, was primarily due to the first target of the stock trading price metric being achieved.
	The excess of the cost of the MacDermid Acquisition over the net of amounts assigned to the fair value of the assets acquired and the liabilities assumed was recorded as goodwill. None of the goodwill recorded in connection with the MacDermid Acquisition is expected to be deductible for tax purposes. As the Company completes its purchase price allocation, it is anticipated that additional adjustments may be recorded relating to the valuations of certain assets, various opening balance sheet contingencies and income tax matters. The Company anticipates that it will complete its purchase price allocation in the second quarter of 2014.  The finalization of the Company's purchase accounting assessment will result in changes in the valuation of assets acquired and liabilities assumed, which the Company does not expect to be material. Based on this preliminary fair valuation, the purchase price was allocated as follows:
	Preliminary Purchase Price Allocation (in thousands):
	Preliminary value assigned:
	Accounts receivable	$	147,400
	Inventories		115,300
	Other current assets		26,200
	Property, plant and equipment		142,800
	Customer relationships		458,400
	Developed technology		155,000
	Tradenames		73,400
	Goodwill		993,800
	Other assets		30,800
	Accounts payable		(55,900	)
	Other current liabilities		(62,100	)
	Long-term debt		(754,200	)
	Non-current deferred tax liability		(140,700	)
	Contingent consideration		(35,500	)
	Redeemable 401(k) plan interest		(21,000	)
	Other liabilities		(66,500	)
	Total purchase price	$	1,007,200
	Certain sellers of MacDermid exchanged their equity in MacDermid for equity in a wholly owned subsidiary, Platform Delaware Holdings, Inc. (“PDH”), and a proportionate share of the contingent consideration described above and an interest in certain MacDermid pending litigation (referred to as “Retaining MacDermid Holdings”).  This 6.76% ownership has been accounted for as a non-controlling interest in the Company’s financial statements.  The holders of the Retaining MacDermid Holdings can exchange their shares for Platform common stock beginning on November 1, 2014 up to 25% a year at their election.  Potential shares of Common Stock issuable upon the exchange are 8,900,000.  This equity is classified as a “Non-controlling interest” in the accompanying Condensed Consolidated Balance Sheets.
	Upon the closing of the MacDermid Acquisition, the MacDermid Savings Plan retained a 3% interest in MacDermid. The fair value of the obligation to purchase these shares of $20,972 was recorded as a redeemable 401(k) interest in the mezzanine section of the Consolidated Balance Sheets at December 31, 2013 since it could be settled in either cash or stock. On March 4, 2014, pursuant to the terms of an Exchange Agreement, dated October 25, 2013, between the Company and the fiduciaries of the MacDermid Savings Plan, the Company acquired the remaining approximately 3% of the MacDermid Plan Shares for approximately $2,600 in cash (which is reflected in “Acquisition of business, net” in the accompanying Condensed Consolidated Statements of Cash Flows) and 1,670,386 shares of the Company’s Common Stock.
	As the Company’s inception date was April 23, 2013, no pro-forma financial disclosures are necessary as all of the results of operations of MacDermid are included in the Successor and Predecessor Periods.
	Other
	During the quarter ended March 31, 2012, MacDermid acquired 95% of the stock of a specialty chemical business in Brazil for a total purchase price of $8,900. This business was acquired to complement the service and product offerings within Brazil and its balance sheet and results of operations have been integrated into the Performance Materials segment. During the first quarter of 2014, the remaining $1,114 purchase price was paid.

Note_3_Inventories

Note 3 - Inventories	3 Months Ended
	Mar. 31, 2014
Inventory Disclosure [Abstract]	'
Inventory Disclosure [Text Block]	'
	3.  INVENTORIES
	The major components of inventory were as follows
		31-Mar-14		31-Dec-13
	Finished goods	$	48,072	$	58,360
	Raw materials and supplies		29,736		29,870
	Equipment		2,062		1,388
	Total inventory, net	$	79,870	$	89,618
	In connection with the MacDermid Acquisition, the fair value assessment of inventory resulted in an increase to finished goods of $35,868 consisting of $23,992 charged through earnings in the prior year and $11,956 charged through the Condensed Consolidated Statement of Operations in the three months ended March 31, 2014 based on our estimated inventory turnover.

Note_4_Property_Plant_and_Equi

Note 4 - Property, Plant and Equipment	3 Months Ended
	Mar. 31, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment Disclosure [Text Block]	'
	4.  PROPERTY, PLANT AND EQUIPMENT
	The major components of property, plant and equipment were as follows:
		31-Mar-14			31-Dec-13
	Land and leasehold improvements	$	29,848		$	31,246
	Buildings and improvements		39,969			41,118
	Machinery, equipment and fixtures		64,518			63,475
			134,335			135,839
	Less: accumulated depreciation		(7,473	)		(3,900	)
			126,862			131,939
	Construction in process		8,881			7,731
	Property, plant and equipment, net	$	135,743		$	139,670
	For the Successor and Predecessor Periods, the Company recorded depreciation expense of $3,573 and $3,152, respectively.

Note_5_Goodwill_and_Intangible

Note 5 - Goodwill and Intangible Assets	3 Months Ended
	Mar. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill and Intangible Assets Disclosure [Text Block]	'
	5.  GOODWILL AND INTANGIBLE ASSETS
	The changes in the carrying amount of goodwill by segment are as follows:
		Performance			Graphic			Total
		Materials			Solutions
	Balance, December 31, 2013	$	773,713		$	229,173		$	1,002,886
	Acquisition adjustments		3,453			-			3,453
	Foreign currency translation and other		(4,129	)		(462	)		(4,591	)
	Balance, March 31, 2014	$	773,037		$	228,711		$	1,001,748
	The carrying value of indefinite-lived intangible assets other than goodwill which consist solely of tradenames was $73,400 at both March 31, 2014 and December 31, 2013.
	Intangible assets subject to amortization were as follows:
		31-Mar-14									31-Dec-13
		Gross Carrying Amount			Accumulated Amortization and Foreign Exchange			Net Book			Gross Carrying Amount		Accumulated Amortization and Foreign Exchange			Net Book
								Value								Value
	Customer lists	$	458,400		$	(14,992	)	$	443,408		$	458,400	$	(2,290	)	$	456,110
	Developed technology		155,000			(6,231	)		148,769			155,000		(1,506	)		153,494
	Total	$	613,400		$	(21,223	)	$	592,177		$	613,400	$	(3,796	)	$	609,604
	Customer relationships have useful lives ranging from 8 to 20 years and developed technology have useful lives ranging between 7 to 10 years. This results in weighted average useful lives for customer relationships and developed technology, of approximately 16 years and 10 years, respectively, for an aggregate weighted average useful life of approximately 15 years at March 31, 2014.
	For the Successor and Predecessor Periods, the Company recorded amortization expense on intangible assets of $13,317 and $6,735, respectively.

Note_6_Equity_Compensation_Pla

Note 6 - Equity Compensation Plans	3 Months Ended
	Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	'
	6.  EQUITY COMPENSATION PLANS
	On October 31, 2013, the Company’s Board of Directors approved the Platform Specialty Products Corporation 2013 Incentive Compensation Plan, and on December 16, 2013 the Board of Directors approved the Platform Specialty Products Corporation Amended and Restated 2013 Incentive Compensation Plan (the “2013 Plan”), which will be submitted to the Company’s stockholders for approval within 12 months. The purpose of the 2013 Plan is to assist the Company and its subsidiaries and other designated affiliates in attracting, motivating, retaining and rewarding high-quality executives and other employees, officers, directors, consultants and other persons who provide services to our Company or its affiliates. The 2013 Plan is to be administered by a committee designated by the Company’s Board of Directors consisting of not less than two directors (the “Committee”); provided, however, that except as otherwise expressly provided in the 2013 Plan, the Board of Directors may exercise any power or authority granted to the Committee under the 2013 Plan. The Committee is authorized to select eligible persons to receive awards, determine the type, number and other terms and conditions of, and all other matters relating to, awards, prescribe award agreements (which need not be identical for each participant), and the rules and regulations for the administration of the 2013 Plan, construe and interpret the 2013 Plan and award agreements, and correct defects, supply omissions or reconcile inconsistencies therein, and make all other decisions and determinations as the Committee may deem necessary or advisable for the administration of the 2013 Plan. The total number of shares of Common Stock of our Company that may be subject to the granting of awards under the 2013 Plan is equal to 15,500,000 shares.
	The Company has granted 329,823 restricted stock units with a maximum value of $7,100 pending approval of the Amended and Restated Incentive Compensation Plan at the annual shareholders meeting. There was no compensation expense associated with these awards for the three months ended March 31, 2014 as an accounting grant date will be established upon approval. The Company also granted 9,242 restricted stock units to directors of the Company that will vest upon approval of the Amended and Restated Incentive Compensation Plan at the annual shareholders meeting. Compensation expense associated with these awards was not material for the three months ended March 31, 2014.
	Effective March 6, 2014, the Board of Directors adopted the Company’s 2014 Employee Stock Purchase Plan (the “ESPP”), subject to approval by our stockholders within 12 months. If stockholder approval is not obtained, then the ESPP and any grants made thereunder will immediately terminate and be null and void. The purpose of the ESPP is (i) to provide eligible employees of the Company and participating companies (as defined in the ESPP) who wish to become stockholders of Platform a convenient method of doing so, (ii) to encourage employees to work in the best interests of Platform’s stockholders, (iii) to support recruitment and retention of qualified employees, and (iv) to provide employees an advantageous means of accumulating long-term investments. The Board of Directors approved a maximum of 5,178,815 shares of the Company’s Common Stock, to be reserved and made available for issuance under the ESPP. As of March 31, 2014, no shares have been issued under the ESPP.
	On April 13, 2007, the Predecessor authorized and issued 2,150,000 Class A Junior Shares (the “A Shares”) to employees who purchased both preferred and common shares of the Predecessor as part of a $7,000 management buy-in of both preferred and common shares of the Predecessor (the “Merger”). Vesting of the A Shares occurred evenly over a five year period and required continued employment. Forfeited A Shares could be reissued at the Board of Directors’ discretion. Holders of the A Shares were not entitled to any dividends at the time that they vest, but were entitled to distributions if declared by the Board of Directors of MacDermid Holdings. Any such distributions, when declared, would be paid in the order of priority specified in the MacDermid Holdings operating agreement. The redemption value of the A Shares was based on a sliding formula which took into account the final valuation of MacDermid at a “liquidity event”, such as an initial public offering or sale of MacDermid. At the point of the liquidity event, the A Shares were to be liquidated in their order of priority or seniority, as compared to each of MacDermid’s debt and equity instruments. If during the liquidity event, there were not enough proceeds to redeem MacDermid’s debt and equity instruments with senior claims, then the A Shares would potentially have a $0 value.
	The A Shares were valued at $1.00 per share for equity compensation expense purposes based upon the issuance price of the common stock in connection with the Merger, which was determined based on various factors including the lack of liquidity of the common stock, the general and industry specific economic outlook and the relative rights of the holders of capital stock of the Predecessor and MacDermid Holdings to receive assets of the Predecessor upon a liquidation event. A key assumption in determining the value of the A Shares was that the Predecessor would attain the performance metrics required for full vesting of the B Shares described below because the number of B Shares vested at the time of any liquidation event would impact the amount of assets available for distribution to the A Shares upon such liquidation event.
	As the A Shares vested, the Predecessor recorded equity based compensation expense and the number of vested A Shares reflected on the balance sheet was increased. For the three months ended March 31, 2013 the Predecessor recorded equity based compensation expense of $3, based upon the vesting of the A Shares. The total intrinsic value of A Shares exercised for the three month period ended March 31, 2013 was $0.
	On April 13, 2007, the Predecessor authorized 1,620,000 B Shares for issuance. In May 2008, the Company issued 1,364,000 Class B Junior Performance Shares (“B Shares”). The B Shares carried a vesting period of one to four years as well as performance conditions when issued.
	The B Shares were modified by resolution of the Predecessor’s Board of Directors on February 28, 2011, subject to MacDermid Holdings member consent, to take into account the divestitures and acquisitions undertaken by MacDermid since 2007 and the difficult global economic conditions that occurred in 2009. MacDermid Holdings member consent was completed on April 4, 2011. The change resulted in the reinstatement of shares previously forfeited under the former performance metrics. As a result of the modification of the performance metrics, the Predecessor determined the estimated fair value of the B Shares as of the modification date to be $0.67 per share. The stock valuation model that the Predecessor utilized and that was used to estimate the fair value of the B Shares considered a number of factors including operating and financial performance, the lack of liquidity of the Predecessor’s common stock and the relative rights of the holders of capital stock of the Predecessor and MacDermid Holdings to receive assets of the Predecessor upon a liquidation event. The key assumptions and estimates in determining the value of the B Shares were (1) the assumption that the Predecessor would attain the modified performance metrics required for full vesting of the B Shares and (2) the estimation of the fair value of the Predecessor’s common stock on the modification date of the B Shares. None of the specific terms of the B Shares, other than their vesting terms and the rights of the holders of the B Shares in a liquidation event relative to the rights of the holders of the common shares, preferred shares and A Shares, impacted the fair value of the B Shares.
	The B Shares were to vest ratably on each of March 31, 2011, 2012, 2013, 2014 and 2015 (each, a “Vesting Date”) if the Predecessor attained the modified performance metrics with respect to the calendar year immediately prior to the year of the applicable Vesting Date (a “Performance Vesting Target”), or upon a change in control. MacDermid met the modified performance metrics for calendar year 2012 resulting in 20% of the B shares vesting as of March 31, 2013.
	During the three months ended March 31, 2013, $36 was recognized as equity compensation expense was recorded related to the B Shares. Compensation expense related to the B Shares is recorded when the Company’s management concludes that the achievement of the performance condition contained in the B Shares is probable.
	On January 29, 2013, the Predecessor authorized for issuance 5,000,000 Class C Junior Shares. The Class C Junior Shares were allocated to three tranches of 1,666,666 shares each and defined as Class C-1 Junior Shares, Class C-2 Junior Shares and Class C-3 Junior Shares (collectively, “C Shares”). The Class C-1 Junior Shares vested upon the grant date of January 29, 2013. Class C-2 Junior Shares were to vest on January 1, 2014 and the Class C-3 Junior Shares were to vest on January 1, 2015. The number of issued and awarded Class C Junior Shares was 4,890,000 shares or 1,630,000 shares each for the Class C-1 Junior Shares, Class C-2 Junior Shares and Class C-3 Junior Shares. The value of the C Shares was measured based upon the performance criteria in the operating agreement of MacDermid Holdings based on the estimated equity value of the Predecessor. The C Shares were to be paid in cash in accordance with the operating agreement of MacDermid Holdings upon a change in control, liquidating event or initial public offering. Payment for the C shares required continued employment through a change in control, liquidating event, or initial public offering. The C Shares were considered liability-classified awards with the related fair value recognized as compensation expense ratably over the performance period, with changes in the fair value of the award cumulatively adjusted through compensation expense each period. During the Predecessor Period no compensation expense was recognized related to the C Shares as a change in control, liquidating event or initial public offering related to the Company (as defined in the MacDermid Holdings operating agreement) was not probable.  The estimated fair value of the Class C Shares (all tranches) was approximately $9,030 at March 31, 2013.

Note_7_Pension_PostRetirement_

Note 7 - Pension, Post-Retirement and Post-Employment Plans	3 Months Ended
	Mar. 31, 2014
Compensation and Retirement Disclosure [Abstract]	'
Pension and Other Postretirement Benefits Disclosure [Text Block]	'
	7.  PENSION, POST-RETIREMENT AND POST-EMPLOYMENT PLANS
	The components of net periodic pension and postretirement benefit costs for the Successor and Predecessor Periods are as follows:
		For the three months						For the three months
		ended March 31, 2014						ended March 31, 2013
		(Successor)						(Predecessor)
	Pension & SERP Benefits:	Domestic			Foreign			Domestic			Foreign
	Net periodic cost (benefit):
	Service cost	$	-		$	208		$	1,078		$	174
	Interest cost on the projected benefit obligation		1,728			755			1,565			768
	Expected return on plan assets		(2,433	)		(898	)		(2,005	)		(1,283	)
	Amortization of prior service cost		-			-			23			-
	Amortization of net loss		-			-			505			135
	Net periodic (benefit) cost	$	(705	)	$	65		$	1,166		$	(206	)
		For the three months						For the three months
		ended March 31, 2014						ended March 31, 2013
		(Successor)						(Predecessor)
	Postretirement Benefits:	Domestic			Foreign			Domestic			Foreign
	Net periodic cost (benefit):
	Service cost	$	14		$	7		$	18		$	11
	Interest cost on the projected benefit obligation		83			8			73			10
	Amortization of prior service cost		-			-			(35	)		7
	Net periodic cost	$	97		$	15		$	56		$	28
	No service cost was recognized in the Successor Period, or will be in future periods, as benefits in the domestic pension plan were frozen in connection with the MacDermid Acquisition.

Note_8_Debt

Note 8 - Debt	3 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	8. DEBT
	The Company’s debt consisted of the following:
		31-Mar-14			31-Dec-13
	Borrowings under lines of credit	$	-		$	-
	First lien secured credit facility, due 2020, interest at the greater of 4.00% or LIBOR plus 3.00%, weighted average interest rate of 4.00% at March 31, 2014		749,338			751,225
	Other		900			1,024
	Total debt		750,238			752,249
	Less: current portion debt		(7,911	)		(7,958	)
	Total long-term debt	$	742,327		$	744,291
	Refinancing
	On June 7, 2013, the Predecessor completed a refinancing arrangement whereby the outstanding Tranche B term loan, Tranche C term loan, revolving credit facility and senior subordinated notes payable were replaced with two new senior secured credit facilities (the “Refinancing”).  The new senior secured credit facilities consist of (i) a $805,000 first lien credit facility allocated between a $755,000 term loan denominated in U.S. Dollars (“first lien term loan”), a $25,000 revolving credit facility denominated in U.S. Dollars and $25,000 multi-currency revolving credit facility and (ii) a $360,000 second lien term loan credit facility denominated in U.S. Dollars (“second lien term loan”).  The first lien term loan and related revolving credit facilities accrue interest at the greater of 4.00% or LIBOR plus 3.00% and has quarterly principal payments of $1,888.  The revolving credit facility portion of the first lien term loan matures June 7, 2018.  The first lien term loan matures June 7, 2020.  The second lien term loan accrued interest at the greater of 7.75% or LIBOR plus 6.75% and matures December 7, 2020.  The first lien term loan was originally issued at a discount of $1,887 and the second lien term loan was issued at a discount of $3,600.  The new senior secured credit facilities are guaranteed by MacDermid Holdings and certain of its direct and indirect wholly owned domestic subsidiaries and are secured by the personal property now owned or hereafter acquired of MacDermid Holdings and certain of its direct and indirect wholly owned domestic subsidiaries and also 65% of the stock of MacDermid Holdings’ first tier foreign subsidiaries, subject to customary exceptions, exclusions and release mechanisms.
	In connection with the MacDermid Acquisition, on October 31, 2013, MacDermid entered into Amendment No. 1 to the First Lien Credit Agreement (the “Amended and Restated First Lien Credit Facility”) and MacDermid paid $373,000 in connection with the repayment of the $360,000 in principal on the second lien credit facility and $13,000 in early termination fees and accrued and unpaid interest. Pursuant to the Amended and Restated First Lien Credit Facility, Platform became a co-borrower on all obligations under the $50,000 Revolving Credit Facility and the term loan (together, the “First Lien Facilities”) and the negative and affirmative covenants contained therein were modified to reflect the new corporate structure. Otherwise, the terms relating to the incremental facility, maturity, indicative margin, LIBOR floor, ranking, guarantors, mandatory prepayments and financial covenants remained unmodified by the amendment. In connection with the MacDermid Acquisition, the first lien term loan was marked to fair value by adding the original discount of $1,775 to the carrying value at the time.
	During the three months ended March 31, 2014, principal and interest payments of $1,888 and $7,512, respectively, were made on the first lien term loan.
	The Company also has letters of credit outstanding of $3,774 at March 31, 2014.  The letters of credit reduce the borrowings available under the new revolving credit facility.
	Predecessor Retired Senior Secured Credit Facility
	On April 12, 2007, the Predecessor closed three new senior secured credit facilities consisting of (i) a $360,000 tranche B term loan credit facility denominated in U.S. Dollars (“tranche B”), (ii) a $250,000 tranche C term loan credit facility denominated in Euros (“tranche C”) and (iii) a $50,000 revolving credit facility denominated in U.S. Dollars.
	During the Predecessor Period, principal and interest payments of $900 and $1,158, respectively, were made on the tranche B term loan.  During the Predecessor Period, principal and interest payments of $647 and $824, respectively, were made on the tranche C term loan.
	During the Predecessor Period, the Company recorded $3,823 of other income related to the remeasurement gain on the foreign currency denominated tranche C term loan.
	In addition to scheduled repayments, the tranche B and tranche C loans contained mandatory prepayment provisions, whereby the Company was required to reduce the outstanding principal amounts of these loans based on excess cash flow (as defined in the credit agreement for the tranche B and tranche C loans) as of the most recent completed fiscal year. During the three months ended March 31, 2013, the Predecessor made a mandatory excess cash flow prepayment, based upon 2012 operating results, of $10,277 on the tranche B term loan and $6,810 on the tranche C term loan.
	Predecessor Retired Revolving Credit Facility
	As discussed above, on April 12, 2007, the Predecessor entered into a $50,000 revolving credit facility. In May 2012, the revolving credit facility was amended and extended; the facility was retired on June 7, 2013 as part of the Refinancing.  There were no balances outstanding under the revolving credit facility on the retirement date. During the Predecessor Period, the Company paid commitment fees of $57 for the revolving credit facility.
	Predecessor Senior Subordinated Notes
	On April 12, 2007, the Predecessor issued $350,000 of senior subordinated notes with a fixed interest rate of 9.50% at par.  As discussed above and as part of the Refinancing, the senior subordinated notes were called on June 7, 2013 and $249,519 of principal and a redemption premium of $9,357 were paid to retire the tendered senior subordinated notes.  Additionally, $105,864 of the new debt proceeds from the refinance and recapitalization were escrowed to pay the outstanding called senior subordinated notes of $100,481.  Additionally, proceeds from the refinance were escrowed for a redemption premium of $3,182 on the called senior subordinated notes outstanding and accrued interest of $2,201 related to these called senior subordinated notes.  The escrowed funds were paid to the holders of the remaining senior subordinated note holders on July 8, 2013. During the Predecessor Period, no principal or interest payments were made on the senior subordinated notes.
	Japanese Senior Secured Bank Debt
	In February 2007, the Predecessor borrowed approximately $15,000 denominated in Japanese Yen in three separate notes that were paid in full by their respective maturity dates between 2009 and 2013. In May 2007 the Predecessor borrowed an additional $7,557, denominated in Japanese Yen which was paid in full in May 2012. In September 2007, the Predecessor borrowed an additional $2,519 denominated in Japanese Yen which was paid in full in July 2013. In October 2009, the Predecessor borrowed $5,569 denominated in Japanese Yen which was paid in full in October 2013.
	During the Predecessor Period, the Company made principal and interest payments of $1,120 and $27, respectively, on Japanese senior secured bank debt.
	Debt Covenants
	The senior secured credit facilities contain various covenants including restrictions on liens, limitations on additional indebtedness, dividends and other distributions, entry into new lines of business, transactions with affiliates, use of loan proceeds, capital expenditures, restricted payments, amendments to organizational documents, accounting changes, sale and leaseback transactions and dispositions. In addition, the new revolving credit facilities requires the Company to comply with certain financial covenants, including a maximum consolidated leverage ratio, a minimum interest coverage ratio and limitations on capital expenditures if the Company’s funding under the revolving credit facility exceeds $12,500 at the end of the fiscal quarter. As of March 31, 2014, the Company was in compliance with the debt covenants contained in the new senior secured credit facilities.
	Other debt facilities
	The Company carries various short-term debt facilities worldwide which are used to fund short-term cash needs.  As of March 31, 2014 and December 31, 2013, there were no borrowings under these other debt facilities.  The Company also has various overdraft facilities available.  At March 31, 2014 and December 31, 2013, the capacity under these overdraft facilities was approximately $20,529 and $22,075, respectively.  As of March 31, 2014, the Company’s overdraft lines bore interest rates ranging from 1% to 6.25%.

Note_9_Derivative_Instruments

Note 9 - Derivative Instruments

3 Months Ended

Mar. 31, 2014

Derivative Instruments and Hedging Activities Disclosure [Abstract]

'

Derivative Instruments and Hedging Activities Disclosure [Text Block]

'

9. DERIVATIVE INSTRUMENTS

In the normal course of business, the Company is exposed to risks relating to changes in foreign currency exchange rates, interest rates and commodity prices. Derivative financial instruments, such as foreign currency exchange rate hedges are used to manage changes in market conditions related to foreign currency exchange rate volatility. All derivatives are recognized on the consolidated balance sheets at fair value at the end of each period. The counterparty to the Company’s derivative agreements is a major international financial institution. The Company continually monitors its positions and the credit ratings of its counterparties, and does not anticipate nonperformance by the counterparties.

Foreign Currency

The Company conducts a significant portion of its business in currencies other than the U.S. Dollar, the currency in which the Company’s consolidated financial statements are reported, and as a result, the Company’s operating results are affected by foreign currency exchange rate volatility relative to the U.S. dollar. The Company’s Autotype subsidiary in the United Kingdom uses the British Pound Sterling (“GBP”) as its functional currency while approximately 25 percent of its revenues are denominated in U.S. Dollars. In order to protect against the risk of a strengthening GBP, the Corporate Treasury Group entered into forward contracts in 2013, on behalf of the Autotype subsidiary to deliver U.S. dollars at a fixed GBP rate and to receive GBP in exchange for the U.S. dollar.

As of March 31, 2014, the aggregate U.S. Dollar notional amount of foreign currency forward contracts, designated as hedges, was $5,000. The Company uses the discounted period-end forward rates methodology to determine market value of its forward contracts.

During the three months ended March 31, 2014 and 2013, $15 and $(780), respectively, of unrealized gains (losses) were recorded in other comprehensive income relating to foreign currency exchange contracts.  During the three months ended March 31, 2014 and 2013, the Company recorded realized gains (losses) of $159 and $(223), respectively, in other income (expense) related to the settlement of foreign exchange contracts.

The following table summarizes foreign currency forward contract derivative instrument amounts as of March 31, 2014, by currency and the portion of the asset that settles within the next twelve months.

Local Currency

U.S. Dollar

Percentage Settled

Dates Contracts

Amount

Amount

Within One Year

are Through

Derivative Assets

Great Britain Pound

£

3,107

$

5,000

100

%

30-Jun-14

The following table summarizes the fair value of derivative instruments reported in the Condensed Consolidated Balance Sheets:

31-Mar-14

31-Dec-13

U.S. Dollar Amount

U.S. Dollar Amount

Derivatives designated as hedging instruments:

Assets Balance Sheet Location

Foreign exchange contracts

Other current assets

$

178

$

163

Total derivative contracts

$

178

$

163

Note_10_Fair_Value_Measurement

Note 10 - Fair Value Measurements	3 Months Ended
	Mar. 31, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Disclosures [Text Block]	'
	10. FAIR VALUE MEASUREMENTS
	The Company determines fair value measurements used in its consolidated financial statements based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction costs, as determined by either the principal market or the most advantageous market. The principal market is the market with the greatest level of activity and volume for the asset or liability. Absent a principal market to measure fair value, the Company has used the most advantageous market, which is the market in which the Company would receive the highest selling price for the asset or pay the lowest price to settle the liability, after considering transaction costs. However, when using the most advantageous market, transaction costs are only considered to determine which market is the most advantageous and these costs are then excluded when applying a fair value measurement.
	Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. The basis for fair value measurements for each level within the hierarchy is described below with Level 1 having the highest priority and Level 3 having the lowest.
	The three levels of the fair value hierarchy are as follows:
	·	Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.
	·	Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in non-active markets; and model derived valuations whose inputs are observable or whose significant valuation drivers are observable.
	·	Level 3 – significant inputs to the valuation model are unobservable and/or reflect the Company’s market assumptions.
	The following tables present the Company’s financial instruments, assets and liabilities that are measured at fair value on a recurring basis:
					Fair Value Measurement Using
			31-Mar-14		Quoted prices in		Significant		Significant
					active markets		other observable		unobservable
					(Level 1)		inputs (Level 2)		inputs (Level 3)
	Asset Category
	Money market accounts		$	80,621	$	80,621	$	-	$	-
	Available for sale equity securities			2,264		1,399		865		-
	Derivatives			178		-		178		-
	Total		$	83,063	$	82,020	$	1,043	$	-
	Liability Category
	Long term contingent consideration		$	47,800	$	-	$	-	$	47,800
					Fair Value Measurement Using
			31-Dec-13		Quoted prices in		Significant		Significant
					active markets		other observable		unobservable
					(Level 1)		inputs (Level 2)		inputs (Level 3)
	Asset Category
	Money market accounts		$	78,633	$	78,633	$	-	$	-
	Available for sale equity securities			2,302		1,470		832		-
	Derivatives			163		-		163		-
	Total		$	81,098	$	80,103	$	995	$	-
	Liability Category
	Long term contingent consideration		$	34,800	$	-	$	-	$	34,800
	Money market accounts are included in cash and cash equivalents in the Condensed Consolidated Balance Sheets.  Available for sale equity securities are included in other long term assets in the Condensed Consolidated Balance Sheets.
	Nonrecurring Fair Value Measurements
	The following table presents the carrying value and estimated fair value of the Company’s first lien credit facility:
			31-Mar-14				31-Dec-13
			Carrying		Fair Value		Carrying		Fair Value
			Value				Value
	First lien credit facility, including current portion		$	749,338	$	750,649	$	751,225	$	752,637
	The following methods and assumptions were used to estimate the fair value of each class of the Company’s financial instruments, assets and liabilities:
	Money market accounts - The Company invests in various money market funds which are managed by financial institutions. These money market funds are not publicly traded, but historically have been highly liquid. The fair value of the money market accounts is determined by the banks based upon the funds’ net asset values (“NAV”). All of the money market accounts currently permit daily investments and redemptions at $1.00 NAV.
	Derivatives - The fair values of foreign currency derivatives were determined using pricing models based upon observable market inputs including both forward and spot prices for the underlying currencies.
	Available for sale equity securities - Equity securities classified as available for sale are measured using quoted market prices at the reporting date multiplied by the quantity held.
	First Lien credit facility– The first lien credit facility is measured using quoted market prices at the reporting date multiplied by the carrying amount of the related debt. Such instruments are valued using Level 2 inputs.

Note_11_Stockholders_Equity

Note 11 - Stockholders' Equity	3 Months Ended
	Mar. 31, 2014
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	11.  STOCKHOLDERS’ EQUITY
	Successor
	Founder Preferred Shares
	On April 25, 2013, the Company issued two preferred shares, one to each of the Mariposa Acquisition, LLC and Berggruen Acquisition Holdings, IV, Ltd, our founder entities (collectively, the “Founders”), for $20.0. In connection with the initial public offering on May 22, 2013, the Founders purchased an additional 1,999,998 preferred shares (“Preferred” shares or stock; no par value) for $20,000. Beginning in 2014, if the average stock price of our shares of Common Stock exceeds $11.50 per share for ten consecutive trading days, which it has, the holders of the Preferred stock receive a dividend in the form of shares of Common Stock equal to 20% of the appreciation of the market price of common shares issued to common shareholders in the initial offering multiplied by total initial offering shares (90,500,000 shares). In the first year a dividend is payable (if any), the dividend amount will be calculated at the calendar year-end based on the appreciated stock price as determined above (the “Dividend Price) compared to the initial offering price of $10.00 per ordinary share. In subsequent years, the dividend amount will be calculated based on the appreciated stock price compared to the highest Dividend Price previously used in calculating the Preferred stock dividends. Dividends are paid for the term the Preferred stock is outstanding. The Preferred shares will be automatically converted into ordinary shares on a one for one basis (i) in the event of a change of control of the Company following an acquisition or (ii) upon the last day of the seventh full financial year following the MacDermid Acquisition, being December 31, 2020 (extendable by the Board of Directors for three additional years). Each Preferred share is convertible into one ordinary share of Common Stock at the option of the holder until December 31, 2020 and has certain voting rights.  No shares were issued or dividends paid in the Successor Period.
	Common Shares
	In connection with the initial public offering on May 22, 2013, the Company issued 88,500,000 common shares (no par value) for gross proceeds of $885,000. Also, on May 22, 2013, the Company issued an aggregate of 29,500 common shares to non-founder directors for $10.00 per share. Each common share has voting rights and winding-up rights.
	Each of the 2,000,000 Preferred shares, 88,500,000 common shares issued in connection with the initial public offering as well as the 29,500 common shares issued to the non-founder directors was issued with a warrant (90,529,500 warrants in aggregate), entitling the holder of each warrant to purchase one-third of common shares with a strike price of $11.50 per common share. Each warrant was exercisable until three years from the date of an acquisition, unless mandatorily redeemed by the Company. The warrants are mandatorily redeemable by the Company at a price of $0.01 should the average market price of a common share exceed $18.00 for 10 consecutive trading days.
	In connection with the MacDermid Acquisition, the Company agreed to apply to list its shares on the New York Stock Exchange and to change its jurisdiction of incorporation from the British Virgin Islands to Delaware.  The Company filed a registration statement on Form S-4 with the SEC to effect these changes.  The registration statement was declared effective on January 22, 2014 and on that same date the Company completed its Domestication. On January 23, 2014, the Company’s Common Stock began trading on the New York Stock Exchange under the ticker symbol “PAH.” On March 4, 2014, pursuant to the terms of an Exchange Agreement, dated October 25, 2013, between the Company and the fiduciaries of the MacDermid Savings Plan, the Company acquired the remaining approximately 3% of the MacDermid Plan Shares for approximately $2,600 in cash (which is reflected in “Acquisition of business, net” in the accompanying Condensed Consolidated Statements of Cash Flows) and 1,670,386 shares of the Company’s Common Stock.
	In connection with the Domestication, (i) each ordinary share of the Company that was issued and outstanding immediately prior to the Domestication was automatically converted into one share of Common Stock (par value $0.01) of the Company, (ii) outstanding options, warrants and other rights to acquire ordinary shares became options, warrants or rights to acquire the corresponding shares of Common Stock of the Company, and (iii)  each Founder Preferred share that was issued and outstanding immediately prior to the Domestication was automatically converted into one share of Series A Preferred Stock of the Company.  In order to fund a portion of the cash consideration for the MacDermid Acquisition in November 2013, the Company conducted an offer to issue shares of Common Stock of the Company in exchange for $10.50 and 3 warrants, up to a maximum of half of the warrants outstanding (the Warrant Exchange Offer”) in which 40,386,840 warrants (representing $141,354 in cash) were exercised and 13,462,280 underlying shares of Common Stock were issued.  In conjunction with the Warrant Exchange Offer not being fully subscribed, on November 13, 2013, the Company issued 380,952 shares at $10.50 per share to the Founders and issued 190,476 shares each to two of its independent directors at $10.50 per share.
	As of March 4, 2014, a mandatory redemption event occurred with respect to all of the Company’s outstanding warrants. The Company fixed April 3, 2014 as the date of the mandatory redemption of the warrants, and accordingly, on or after that date, holders of warrants had no further rights with regard to such warrants except to receive $0.01 per warrant. Subsequent to March 31, 2014, an additional 3,755,232 warrants were exercised for 1,251,744 common shares resulting in proceeds to the Company of $14,395. On April 3, 2014, Platform completed the mandatory redemption of the remaining 8,580 outstanding warrants for $0.01 per warrant.
	During the three months ended March 31, 2014, the Company issued 14,996,909 shares of Common Stock in connection with the exercise of a total of 44,978,850 warrants and issuances of shares of Common Stock to employees. At March 31, 2014, there were 3,763,812 warrants outstanding.
	Non-Controlling Interest
	In connection with the MacDermid Acquisition, certain sellers elected to receive shares of common stock of Platform’s subsidiary PDH (the “PDH Common Stock”) representing approximately $97,500, which may be exchanged for shares of Platform’s Common Stock at a rate of 25% per year over a four year period. Such PDH Common Stock is classified as a non-controlling interest on the Condensed Consolidated Balance Sheets at March 31, 2014 and December 31, 2013 and will continue to be until such time as it is exchanged for Platform’s Common Stock. As the holders of PDH Common Stock have a 6.76% interest in PDH, approximately $1,314 of net income has been allocated to them for the three months ended March 31, 2014 and is included in the accompanying Condensed Consolidated Statements of Operations.
	A reconciliation of consolidated changes in equity for the three months ended March 31, 2014 (Successor) and March 31, 2013 (Predecessor) is as follows:
	Successor
		Preferred Stock				Common Stock
		Shares		Amount		Shares		Amount			Additional			Accumulated Deficit			Accumulated other			Total Stockholders' Equity			Non-			Total equity
											Paid-in						comprehensive income (loss)						controlling interest
											Capital
	Balance at December 31, 2013		2,000,000	$	-		103,571,941	$	-		$	1,212,038		$	(194,222	)	$	14,779		$	1,032,595		$	96,021		$	1,128,616
	Impact of Domestication		-		20		-		1,016			(1,036	)		-			-			-			-			-
	Issuance of 3,959 common shares @ $11.00 per share on January 5, 2014		-		-		3,959		-			44			-			-			44			-			44
	Exercise of warrants for 14,992,950 common shares @ $11.50 per share		-		-		14,992,950		150			172,269			-			-			172,419			-			172,419
	Issuance of 1,670,386 common shares @$11.00 per share in connection with 401(k) Exchange Agreement		-		-		1,670,386		16			18,358			-			-			18,374			-			18,374
	Net (loss) income		-		-		-		-			-			(7,417	)		-			(7,417	)		1,469			(5,948	)
	Foreign currency translation adjustments		-		-		-		-			-			-			(9,276	)		(9,276	)		(5	)		(9,281	)
	Pension and postretirement plans, tax benefit of $11		-		-		-		-			-			-			11			11			-			11
	Derivatives valuation, net of tax expense of $11		-		-		-		-			-			-			4			4			-			4
	Unrealized gain on available for sale equity securities, net of tax benefit of $18		-		-		-		-			-			-			(34	)		(34	)		-			(34	)
	Dividend paid to non-controlling interest partner		-		-		-		-			-			-			-			-			(174	)		(174	)
	Balance at March 31, 2014		2,000,000	$	20		120,239,236	$	1,182		$	1,401,673		$	(201,639	)	$	5,484		$	1,206,720		$	97,311		$	1,304,031
	Predecessor
		Series A		Common		Additional		Accumulated			Accumulated			Treasury			Total			Non-			Total equity
		Preferred		Shares		Paid-In		deficit			other			Stock			Stockholders'			controlling			(deficit)
		Shares				Capital					comprehensive						Equity			interest
											income (loss)
	Balance at December 31, 2012	$	525,027	$	50,000	$	2,318	$	(273,086	)	$	(30,270	)	$	(1,264	)	$	272,725		$	(288	)	$	272,437
	Net income		-		-		-		15,248			-			-			15,248			89			15,337
	Equity compensation		-		-		39		-			-			-			39			-			39
	Accrual of paid in kind dividend on cumulative preferred shares		11,794		-		-		(11,794	)		-			-			-			-			-
	Foreign currency translation adjustments		-		-		-		-			(16,524	)		-			(16,524	)		(32	)		(16,556	)
	Derivatives valuation, net of tax  benefit of $273		-		-		-		-			(507	)		-			(507	)		-			(507	)
	Unrealized loss on available for sale equity securities, net of tax expense of $51		-		-		-		-			94			-			94			-			94
	Dividend paid to non-controlling interest partner		-		-		-		-			-			-			-			(173	)		(173	)
	Contribution from non-controlling interest		-		-		-		-			-			-			-			17			17
	Balance at March 31, 2013	$	536,821	$	50,000	$	2,357	$	(269,632	)	$	(47,207	)	$	(1,264	)	$	271,075		$	(387	)	$	270,688

Note_12_Earnings_Per_Share

Note 12 - Earnings Per Share	3 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share [Text Block]	'
	12.  EARNINGS PER SHARE
	A computation of the weighted average shares outstanding for the Successor Period follows. No such computation is necessary for the Predecessor Period.
	(in thousands)	Three months ended
		31-Mar-14
	Weighted average shares outstanding:
	Basic		107,160
	Convertible securities		-	1
	Diluted		107,160
	1 No share adjustments are included in the dilutive weighted average shares outstanding computation as the three months ended March 31, 2014 resulted in a net loss.
	At March 31, 2014, weighted average warrants to purchase 4.5 million shares of the Company’s common stock, were outstanding during the three months ended March 31, 2014, but were not included in the computation of diluted shares as the effect would be anti-dilutive.  Weighted average options to purchase 0.1 million shares of the Company’s common stock, were outstanding during the three months ended March 31, 2014, but were not included in the computation of diluted shares as the effect would be anti-dilutive.
	The number of shares contingently issuable for the contingent consideration during the three months ended March 31, 2014 was 0.5 million, but were not included in the computation of diluted shares as the effect would be anti-dilutive.  The number of shares contingently issuable for the founder preferred share dividend right during the three months ended March 31, 2014 was 8.8 million, but were not included in the computation of diluted shares as the effect would be anti-dilutive.
	The number of shares issuable upon conversion of the PDH non-controlling interest and founder preferred shares was 8.8 million and 2.0 million, respectively, but were not included in the computation of diluted shares as the effect would be anti-dilutive.  Weighted average shares issuable upon conversion of the 401k exchange rights were 1.1 million, but were not included in the computation of diluted shares as the effect would be anti-dilutive.

Note_13_Contingencies_Environm

Note 13 - Contingencies, Environmental and Legal Matters	3 Months Ended
	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	13. CONTINGENCIES, ENVIRONMENTAL AND LEGAL MATTERS
	Asset Retirement Obligations
	The Company has recognized asset retirement obligations (“AROs”) for properties where it can make a reasonable estimate of the future expenditures necessary to satisfy the related obligations. The Company considers identified legally enforceable obligations, estimated settlement dates and appropriate discount and inflation rates in calculating the fair value of its AROs. At March 31, 2014 and December 31, 2013, the Company has accrued $4,864 and $4,765, respectively, for its AROs at sites in the U.S., Europe and Japan.  The AROs are included in “Other long-term liabilities” in the accompanying Condensed Consolidated Balance Sheets as of March 31, 2014 and December 31, 2013.
	Environmental
	The Company is a manufacturer and distributor of specialty chemical products, and is exposed to claims with respect to environmental cleanup or other matters, including those in connection with the disposal of hazardous materials.  The Company is subject to extensive domestic and foreign laws and regulations relating to environmental protection and worker health and safety, including those governing discharges of pollutants into the air and water, the management and disposal of hazardous substances and wastes, and the cleanup of contaminated properties.  The Company has incurred, and will continue to incur, costs and capital expenditures in complying with these laws and regulations.  Additional costs could be incurred, including cleanup costs, fines, sanctions, and third-party claims, as a result of violations of or liabilities under environmental laws.
	Remediation activities vary substantially in duration and cost from site to site. These activities, and their associated costs, depend on the mix of unique site characteristics, evolving remediation technologies, diverse regulatory agencies and enforcement policies, as well as the presence or absence of potentially responsible parties. The Company has received notices of violation with respect to instances of non-compliance with environmental laws. A number of facilities and former facilities of the Company have been environmentally impacted from historic operations and some facilities are in the process of being investigated and remediated. As of March 31, 2014 and December 31, 2013, $2,816 and $2,896, respectively, was reserved for various environmental matters. Ultimate costs may vary from current estimates, and the discovery of additional contaminants at these facilities or other sites, or the imposition of additional cleanup obligations or third-party claims relating thereto could result in additional costs.  Management believes that any possible losses related to environmental remediation in addition to the amounts recorded as of March 31, 2014 and December 31, 2013 would not be material to the Company’s consolidated financial position, results of operations or cash flows.
	Legal Proceedings
	From time to time, the Company is involved in various legal proceedings in the normal course of its business. Management believes that the resolution of these claims, to the extent not covered by insurance, will not individually or in the aggregate, have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows. As of March 31, 2014 and December 31, 2013, the Company has reserved approximately $3,708 and $2,881, respectively, for its outstanding legal proceedings.

Note_14_Income_Taxes

Note 14 - Income Taxes	3 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	14. INCOME TAXES
	The tax impact of the year to date fair value adjustment to the long term contingent consideration liability was fully recorded in the interim period as a reliable estimate of the full year adjustment could not be reasonably made.

Note_15_Related_Party_Transact

Note 15 - Related Party Transactions	3 Months Ended
	Mar. 31, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure [Text Block]	'
	15.  RELATED PARTY TRANSACTIONS
	Immediately prior to the closing of the MacDermid Acquisition, each holder of a portion of MacDermid Holdings not owned by Platform (each, a “Retaining Holder”), including certain officers of MacDermid, executed a Retaining Holder Securityholders’ Agreement (a “RHSA”) with the Company pursuant to which they agreed to exchange their respective interests in MacDermid Holdings for PDH Common Stock of Platform’s subsidiary PDH, at an exchange rate of $11.00 per share plus, with respect to the common, class A and class B unit equity interests of MacDermid Holdings held by the Retaining Holder (i) a proportionate share of a contingent interest in certain pending litigation, and (ii) a proportionate share of up to $100 million of contingent purchase price payable upon the attainment of certain EBITDA and stock trading price performance metrics during the seven-year period following the Closing Date as discussed further in Note 2. Immediately prior to the closing of the MacDermid Acquisition, members of MacDermid management and certain affiliates, including certain officers of MacDermid, contributed all or a portion of their MacDermid Holdings interests to Tartan Holdings, LLC, a newly-formed Delaware limited liability company (“Tartan”), and Tartan agreed to receive the PDH Common Stock in exchange for such MacDermid Holdings equity interests. The resulting noncontrolling interest percentage for the Retaining Holders was 6.76%.
	On October 31, 2013, the Company entered into an Advisory Services Agreement with Mariposa Capital, LLC, an affiliate of one of our founder directors. Under this agreement, Mariposa Capital, LLC will provide certain advisory services. In connection with these services, Mariposa Capital, LLC will be entitled to receive an annual fee equal to $2,000, payable in quarterly installments. This agreement will expire on October 31, 2014 but will be automatically renewed for successive one-year terms unless either party notifies the other party in writing of its intention not to renew this agreement no later than 90 days prior to the expiration of the term. This agreement may only be terminated by the Company upon a vote of a majority of its directors. In the event that this agreement is terminated by the Company, the effective date of the termination will be six months following the expiration of the initial term or a renewal term, as the case may be. Advisory fees paid to Mariposa for the three months ended March 31, 2014 were $500.
	On November 7, 2013, the Company entered into a registration rights agreement with Pershing Square Capital Management, L.P. (“Pershing Square”), the beneficial owner of approximately 31.0% of the Company’s outstanding shares. Those shares were acquired by Pershing Square in the initial public offering and the Warrant Exchange Offer. Pursuant to the agreement, for so long as any of the included funds managed by Pershing Square holds any Platform shares, the Company agreed to cooperate with such holders’ reasonable requests to facilitate any proposed sale of shares by the requesting holder(s) in accordance with the provisions of Rule 144 or any successor rule (“Rule 144”) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), including, without limitation, by complying with the current public information requirements of Rule 144 and providing opinions of counsel, to the extent required. Additionally, the Company agreed that promptly after becoming eligible to utilize a Form S-3 registration statement, the Company will file with the SEC a registration statement on Form S-3 registering (among other securities) the resale of the Company shares held by the holders and use its commercially reasonable efforts to have such registration statement declared effective as soon as practicable after its filing. The Company’s obligations under the registration rights agreement shall terminate on the earlier of (i) the date on which all of a holder’s shares have been sold, and (ii) the date on which all of a holder’s shares may be sold pursuant to Rule 144 without volume or other restrictions.
	For the Predecessor Period, the Company paid management fees of $102 to Court Square Capital Partners II LP (“Court Square”), an investor.  Three of MacDermid’s board members prior to the MacDermid Acquisition were employees of Court Square.
	For the Predecessor Period, the Company paid management fees to Weston Presidio, an investor, of $23.

Note_16_Restructuring_Activiti

Note 16 - Restructuring Activities	3 Months Ended
	Mar. 31, 2014
Restructuring and Related Activities [Abstract]	'
Restructuring and Related Activities Disclosure [Text Block]	'
	16.  RESTRUCTURING ACTIVITIES
	The Company continuously evaluates all operations to identify opportunities to improve profitability by leveraging existing infrastructure to reduce operating costs and respond to overall economic conditions.  The Predecessor implemented certain restructuring actions which were intended to better align the Company’s manufacturing capacity, eliminate excess capacity by lowering operating costs, and streamline the organizational structure for improved long-term profitability. The restructuring actions consist of facility consolidations and closures and employee terminations.  The Company expects to incur incremental manufacturing costs at the operating locations impacted by the restructuring actions during the related restructuring implementation period. The restructuring plans initiated in the three months ended March 31, 2013 primarily related to the consolidation of manufacturing processes which affected a manufacturing facility in the Graphic Solutions segment.
	During the three months ended March 31, 2013, the Company recorded $1,606 of restructuring expense primarily relating to the elimination of certain positions in both the Graphic Solutions and the Performance Materials segments.  There were no restructuring charges recorded for the three months ended March 31, 2014. As of March 31, 2014, the Company has accrued restructuring costs of $1,311 that are anticipated to be paid out in the next twelve months.
	The activity in the restructuring liabilities for the three months ended March 31, 2014 (Successor) and 2013 (Predecessor) was as follows:
				For the Successor Period
	Successor	Balance,		Charges to		Cash			Non-cash			Total Costs			Balance,
		December 31,		Expense		Payments			Adjustments			and			March 31,
		2013										Adjustments			2014
	Graphic Solutions:
	Severance and other benefits	$	699	$	-	$	(202	)	$			$	(202	)	$	497
	Total Graphics Solutions		699		-		(202	)		-			(202	)		497
	Performance Materials:
	Severance and other benefits		1,330				(516	)					(516	)		814
	Total Performance Materials		1,330		-		(516	)		-			(516	)		814
	Total restructuring liability	$	2,029	$	-	$	(718	)	$	-		$	(718	)	$	1,311
				For the Predecessor Period
	Predecessor	Balance,		Charges to		Cash			Non-cash			Total Costs			Balance,
		December 31,		Expense		Payments			Adjustments			and			March 31,
		2012										Adjustments			2013
	Graphic Solutions:
	Severance and other benefits	$	-	$	1,504	$	(57	)	$	-		$	1,447		$	1,447
	Total Graphics Solutions		-		1,504		(57	)		-			1,447			1,447
	Performance Materials:
	Severance and other benefits		632		102		(85	)		(19	)		(2	)		630
	Total Performance Materials		632		102		(85	)		(19	)		(2	)		630
	Total restructuring liability	$	632	$	1,606	$	(142	)	$	(19	)	$	1,445		$	2,077

Note_17_Segment_Information

Note 17 - Segment Information	3 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
Segment Reporting Disclosure [Text Block]	'
	17.  SEGMENT INFORMATION
	The Company’s operations are organized into two reportable segments: Performance Materials and Graphic Solutions.  The segments represent businesses for which separate financial information is utilized by the chief operating decision maker (the “CODM”) for purpose of allocating resources and evaluating performance. Each of the reportable segments has its own president who report to the CODM.
	The Performance Materials segment manufactures and markets dynamic chemistry solutions that are used in the electronics, automotive and oil and gas production and drilling industries. Its products include surface and coating materials and water-based hydraulic control fluids. In conjunction with the sale of these products, we provide extensive technical service and support to ensure superior performance of their application. Within the Performance Materials segment, the Company has two primary categories of products. Industrial products are materials used to improve the performance or look of a component of an industrial part or process.  Electronic products are materials used to manufacture and improve the performance of circuit boards and similar electronic items.
	The Graphic Solutions segment primarily produces and markets photopolymers through an extensive line of flexographic plates that are used in the commercial packaging and printing industries. The Company evaluates the performance of its segments based on net sales and operating profit. Operating profit for each segment includes net sales to third parties, related cost of sales and operating expenses directly attributable to the segment. Operating profit for each segment includes an allocation of corporate costs such as corporate salary and wages, equity compensation expense and legal costs.
	The following table summarizes financial information regarding each reportable segment’s results of operations for the periods presented:
		For the three months			For the three months
		ended March 31, 2014			ended March 31, 2013
		(Successor)			(Predecessor)
	Net Sales:
	Performance Materials	$	143,111		$	138,824
	Graphic Solutions		40,615			43,308
	Consolidated net sales		183,726			182,132
	Operating (loss) profit:
	Performance Materials		8,839			21,447
	Graphic Solutions		(4,847	)		8,329
	Consolidated operating profit	$	3,992		$	29,776

Note_18_Subsequent_Events

Note 18 - Subsequent Events	3 Months Ended
	Mar. 31, 2014
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	18.  SUBSEQUENT EVENTS
	On April 16, 2014, Platform entered into a Stock and Asset Purchase Agreement (the “Agreement”) with Chemtura Corporation, a Delaware corporation (“Chemtura,” and together with certain of its subsidiaries, the “Sellers”) pursuant to which Platform will acquire the Sellers’ agrochemicals business, Chemtura AgroSolutions, consisting of the manufacture, distribution, marketing and sale of seed treatments and crop protection in niche markets across seven major product lines – seed treatments, insecticides, miticides, herbicides, fungicides, plant growth regulators and adjuvants, for approximately $1.00 billion, consisting of $950 million in cash, subject to working capital and other adjustments, 2,000,000 shares of Platform’s Common Stock and the assumption of certain liabilities by Platform (the “Chemtura Acquisition”). The closing of the Chemtura Acquisition is subject to the satisfaction or waiver of certain customary and other closing conditions for transactions of this type, including expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and approvals of government authorities.
	In connection with the Agreement, on April 16, 2014, Platform entered into a commitment letter (the “Debt Commitment Letter”) with Barclays Bank PLC for (i) $600 million of incremental first lien term loans (the “First Lien Facility”) to be incurred under our amended and restated credit agreement dated as of June 7, 2013 (as amended, restated and/or otherwise modified on October 31, 2013 and from time to time, the “Existing Credit Agreement”) and (ii) a second lien facility (the “Second Lien Facility” and together with the First Lien Facility, the “Facilities”) in an aggregate principal amount of $120 million for the purposes of financing the Chemtura Acquisition and the fees and expenses in connection therewith, on the terms and subject to the conditions set forth in the Debt Commitment Letter. The Facilities will be subject to representations, warranties and covenants that are substantially as set forth in the Existing Credit Agreement, which was previously filed as Exhibit 10.13 to Platform’s registration statement on Form S-4 filed with the SEC on January 2, 2014, and other conditions precedent as defined in the Debt Commitment Letter).

Note_2_Acquisitions_of_Busines1

Note 2 - Acquisitions of Businesses (Tables)	3 Months Ended
	Mar. 31, 2014
Business Combinations [Abstract]	'
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	'
	Preliminary Purchase Price Allocation (in thousands):
	Preliminary value assigned:
	Accounts receivable	$	147,400
	Inventories		115,300
	Other current assets		26,200
	Property, plant and equipment		142,800
	Customer relationships		458,400
	Developed technology		155,000
	Tradenames		73,400
	Goodwill		993,800
	Other assets		30,800
	Accounts payable		(55,900	)
	Other current liabilities		(62,100	)
	Long-term debt		(754,200	)
	Non-current deferred tax liability		(140,700	)
	Contingent consideration		(35,500	)
	Redeemable 401(k) plan interest		(21,000	)
	Other liabilities		(66,500	)
	Total purchase price	$	1,007,200

Note_3_Inventories_Tables

Note 3 - Inventories (Tables)	3 Months Ended
	Mar. 31, 2014
Inventory Disclosure [Abstract]	'
Schedule of Inventory, Current [Table Text Block]	'
		31-Mar-14		31-Dec-13
	Finished goods	$	48,072	$	58,360
	Raw materials and supplies		29,736		29,870
	Equipment		2,062		1,388
	Total inventory, net	$	79,870	$	89,618

Note_4_Property_Plant_and_Equi1

Note 4 - Property, Plant and Equipment (Tables)	3 Months Ended
	Mar. 31, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment [Table Text Block]	'
		31-Mar-14			31-Dec-13
	Land and leasehold improvements	$	29,848		$	31,246
	Buildings and improvements		39,969			41,118
	Machinery, equipment and fixtures		64,518			63,475
			134,335			135,839
	Less: accumulated depreciation		(7,473	)		(3,900	)
			126,862			131,939
	Construction in process		8,881			7,731
	Property, plant and equipment, net	$	135,743		$	139,670

Note_5_Goodwill_and_Intangible1

Note 5 - Goodwill and Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Goodwill [Table Text Block]	'
		Performance			Graphic			Total
		Materials			Solutions
	Balance, December 31, 2013	$	773,713		$	229,173		$	1,002,886
	Acquisition adjustments		3,453			-			3,453
	Foreign currency translation and other		(4,129	)		(462	)		(4,591	)
	Balance, March 31, 2014	$	773,037		$	228,711		$	1,001,748
Schedule of Finite-Lived Intangible Assets [Table Text Block]	'
		31-Mar-14									31-Dec-13
		Gross Carrying Amount			Accumulated Amortization and Foreign Exchange			Net Book			Gross Carrying Amount		Accumulated Amortization and Foreign Exchange			Net Book
								Value								Value
	Customer lists	$	458,400		$	(14,992	)	$	443,408		$	458,400	$	(2,290	)	$	456,110
	Developed technology		155,000			(6,231	)		148,769			155,000		(1,506	)		153,494
	Total	$	613,400		$	(21,223	)	$	592,177		$	613,400	$	(3,796	)	$	609,604

Note_7_Pension_PostRetirement_1

Note 7 - Pension, Post-Retirement and Post-Employment Plans (Tables)	3 Months Ended
	Mar. 31, 2014
Compensation and Retirement Disclosure [Abstract]	'
Schedule of Net Benefit Costs [Table Text Block]	'
		For the three months						For the three months
		ended March 31, 2014						ended March 31, 2013
		(Successor)						(Predecessor)
	Pension & SERP Benefits:	Domestic			Foreign			Domestic			Foreign
	Net periodic cost (benefit):
	Service cost	$	-		$	208		$	1,078		$	174
	Interest cost on the projected benefit obligation		1,728			755			1,565			768
	Expected return on plan assets		(2,433	)		(898	)		(2,005	)		(1,283	)
	Amortization of prior service cost		-			-			23			-
	Amortization of net loss		-			-			505			135
	Net periodic (benefit) cost	$	(705	)	$	65		$	1,166		$	(206	)
		For the three months						For the three months
		ended March 31, 2014						ended March 31, 2013
		(Successor)						(Predecessor)
	Postretirement Benefits:	Domestic			Foreign			Domestic			Foreign
	Net periodic cost (benefit):
	Service cost	$	14		$	7		$	18		$	11
	Interest cost on the projected benefit obligation		83			8			73			10
	Amortization of prior service cost		-			-			(35	)		7
	Net periodic cost	$	97		$	15		$	56		$	28

Note_8_Debt_Tables

Note 8 - Debt (Tables)	3 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Schedule of Debt [Table Text Block]	'
		31-Mar-14			31-Dec-13
	Borrowings under lines of credit	$	-		$	-
	First lien secured credit facility, due 2020, interest at the greater of 4.00% or LIBOR plus 3.00%, weighted average interest rate of 4.00% at March 31, 2014		749,338			751,225
	Other		900			1,024
	Total debt		750,238			752,249
	Less: current portion debt		(7,911	)		(7,958	)
	Total long-term debt	$	742,327		$	744,291

Note_9_Derivative_Instruments_

Note 9 - Derivative Instruments (Tables)

3 Months Ended

Mar. 31, 2014

Derivative Instruments and Hedging Activities Disclosure [Abstract]

'

Schedule of Derivative Instruments [Table Text Block]

'

Local Currency

U.S. Dollar

Percentage Settled

Dates Contracts

Amount

Amount

Within One Year

are Through

Derivative Assets

Great Britain Pound

£

3,107

$

5,000

100

%

30-Jun-14

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]

'

31-Mar-14

31-Dec-13

U.S. Dollar Amount

U.S. Dollar Amount

Derivatives designated as hedging instruments:

Assets Balance Sheet Location

Foreign exchange contracts

Other current assets

$

178

$

163

Total derivative contracts

$

178

$

163

Note_10_Fair_Value_Measurement1

Note 10 - Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2014
Fair Value Disclosures [Abstract]	'
Fair Value, Assets Measured on Recurring Basis [Table Text Block]	'
				Fair Value Measurement Using
		31-Mar-14		Quoted prices in		Significant		Significant
				active markets		other observable		unobservable
				(Level 1)		inputs (Level 2)		inputs (Level 3)
	Asset Category
	Money market accounts	$	80,621	$	80,621	$	-	$	-
	Available for sale equity securities		2,264		1,399		865		-
	Derivatives		178		-		178		-
	Total	$	83,063	$	82,020	$	1,043	$	-
	Liability Category
	Long term contingent consideration	$	47,800	$	-	$	-	$	47,800
				Fair Value Measurement Using
		31-Dec-13		Quoted prices in		Significant		Significant
				active markets		other observable		unobservable
				(Level 1)		inputs (Level 2)		inputs (Level 3)
	Asset Category
	Money market accounts	$	78,633	$	78,633	$	-	$	-
	Available for sale equity securities		2,302		1,470		832		-
	Derivatives		163		-		163		-
	Total	$	81,098	$	80,103	$	995	$	-
	Liability Category
	Long term contingent consideration	$	34,800	$	-	$	-	$	34,800
Fair Value Measurements, Nonrecurring [Table Text Block]	'
		31-Mar-14				31-Dec-13
		Carrying		Fair Value		Carrying		Fair Value
		Value				Value
	First lien credit facility, including current portion	$	749,338	$	750,649	$	751,225	$	752,637

Note_11_Stockholders_Equity_Ta

Note 11 - Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2014																											Mar. 31, 2013
Stockholders' Equity Note [Abstract]	'																											'
Schedule of Stockholders Equity [Table Text Block]	'																											'
	Successor																											Predecessor
																													Series A		Common		Additional		Accumulated			Accumulated			Treasury			Total			Non-			Total equity
		Preferred Stock				Common Stock																							Preferred		Shares		Paid-In		deficit			other			Stock			Stockholders'			controlling			(deficit)
		Shares		Amount		Shares		Amount		Additional			Accumulated Deficit			Accumulated other			Total Stockholders' Equity			Non-			Total equity				Shares				Capital					comprehensive						Equity			interest
										Paid-in						comprehensive income (loss)						controlling interest																income (loss)
										Capital																		Balance at December 31, 2012	$	525,027	$	50,000	$	2,318	$	(273,086	)	$	(30,270	)	$	(1,264	)	$	272,725		$	(288	)	$	272,437
																												Net income		-		-		-		15,248			-			-			15,248			89			15,337
	Balance at December 31, 2013		2,000,000	$	-		103,571,941	$	-	$	1,212,038		$	(194,222	)	$	14,779		$	1,032,595		$	96,021		$	1,128,616		Equity compensation		-		-		39		-			-			-			39			-			39
	Impact of Domestication		-		20		-		1,016		(1,036	)		-			-			-			-			-		Accrual of paid in kind dividend on cumulative preferred shares		11,794		-		-		(11,794	)		-			-			-			-			-
	Issuance of 3,959 common shares @ $11.00 per share on January 5, 2014		-		-		3,959		-		44			-			-			44			-			44		Foreign currency translation adjustments		-		-		-		-			(16,524	)		-			(16,524	)		(32	)		(16,556	)
	Exercise of warrants for 14,992,950 common shares @ $11.50 per share		-		-		14,992,950		150		172,269			-			-			172,419			-			172,419		Derivatives valuation, net of tax  benefit of $273		-		-		-		-			(507	)		-			(507	)		-			(507	)
	Issuance of 1,670,386 common shares @$11.00 per share in connection with 401(k) Exchange Agreement		-		-		1,670,386		16		18,358			-			-			18,374			-			18,374		Unrealized loss on available for sale equity securities, net of tax expense of $51		-		-		-		-			94			-			94			-			94
	Net (loss) income		-		-		-		-		-			(7,417	)		-			(7,417	)		1,469			(5,948	)	Dividend paid to non-controlling interest partner		-		-		-		-			-			-			-			(173	)		(173	)
	Foreign currency translation adjustments		-		-		-		-		-			-			(9,276	)		(9,276	)		(5	)		(9,281	)	Contribution from non-controlling interest		-		-		-		-			-			-			-			17			17
	Pension and postretirement plans, tax benefit of $11		-		-		-		-		-			-			11			11			-			11		Balance at March 31, 2013	$	536,821	$	50,000	$	2,357	$	(269,632	)	$	(47,207	)	$	(1,264	)	$	271,075		$	(387	)	$	270,688
	Derivatives valuation, net of tax expense of $11		-		-		-		-		-			-			4			4			-			4
	Unrealized gain on available for sale equity securities, net of tax benefit of $18		-		-		-		-		-			-			(34	)		(34	)		-			(34	)
	Dividend paid to non-controlling interest partner		-		-		-		-		-			-			-			-			(174	)		(174	)
	Balance at March 31, 2014		2,000,000	$	20		120,239,236	$	1,182	$	1,401,673		$	(201,639	)	$	5,484		$	1,206,720		$	97,311		$	1,304,031

Note_12_Earnings_Per_Share_Tab

Note 12 - Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'
	(in thousands)	Three months ended
		31-Mar-14
	Weighted average shares outstanding:
	Basic		107,160
	Convertible securities		-	1
	Diluted		107,160

Note_16_Restructuring_Activiti1

Note 16 - Restructuring Activities (Tables)	3 Months Ended
	Mar. 31, 2014
Restructuring and Related Activities [Abstract]	'
Restructuring and Related Costs [Table Text Block]	'
				For the Successor Period
	Successor	Balance,		Charges to		Cash			Non-cash			Total Costs			Balance,
		December 31,		Expense		Payments			Adjustments			and			March 31,
		2013										Adjustments			2014
	Graphic Solutions:
	Severance and other benefits	$	699	$	-	$	(202	)	$			$	(202	)	$	497
	Total Graphics Solutions		699		-		(202	)		-			(202	)		497
	Performance Materials:
	Severance and other benefits		1,330				(516	)					(516	)		814
	Total Performance Materials		1,330		-		(516	)		-			(516	)		814
	Total restructuring liability	$	2,029	$	-	$	(718	)	$	-		$	(718	)	$	1,311
				For the Predecessor Period
	Predecessor	Balance,		Charges to		Cash			Non-cash			Total Costs			Balance,
		December 31,		Expense		Payments			Adjustments			and			March 31,
		2012										Adjustments			2013
	Graphic Solutions:
	Severance and other benefits	$	-	$	1,504	$	(57	)	$	-		$	1,447		$	1,447
	Total Graphics Solutions		-		1,504		(57	)		-			1,447			1,447
	Performance Materials:
	Severance and other benefits		632		102		(85	)		(19	)		(2	)		630
	Total Performance Materials		632		102		(85	)		(19	)		(2	)		630
	Total restructuring liability	$	632	$	1,606	$	(142	)	$	(19	)	$	1,445		$	2,077

Note_17_Segment_Information_Ta

Note 17 - Segment Information (Tables)	3 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
Schedule of Segment Reporting Information, by Segment [Table Text Block]	'
		For the three months			For the three months
		ended March 31, 2014			ended March 31, 2013
		(Successor)			(Predecessor)
	Net Sales:
	Performance Materials	$	143,111		$	138,824
	Graphic Solutions		40,615			43,308
	Consolidated net sales		183,726			182,132
	Operating (loss) profit:
	Performance Materials		8,839			21,447
	Graphic Solutions		(4,847	)		8,329
	Consolidated operating profit	$	3,992		$	29,776

Note_1_Basis_of_Presentation_D

Note 1 - Basis of Presentation (Details) (USD $)	3 Months Ended		0 Months Ended	1 Months Ended
In Millions, except Per Share data, unless otherwise specified	Mar. 31, 2014	Jan. 23, 2014	Mar. 04, 2014	Oct. 31, 2013
			MacDermid [Member]	MacDermid [Member]
Note 1 - Basis of Presentation (Details) [Line Items]	'	'	'	'
Business Acquisition, Percentage of Ownership	'	'	3.00%	97.00%
Share Price (in Dollars per share)	'	$0.01	'	'
Prior Period Reclassification Adjustment (in Dollars)	$4	'	'	'

Note_2_Acquisitions_of_Busines2

Note 2 - Acquisitions of Businesses (Details) (USD $)

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2012

Mar. 31, 2014

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Oct. 31, 2013

Mar. 31, 2014

Mar. 04, 2014

Jan. 31, 2014

Oct. 31, 2013

Mar. 04, 2014

Mar. 31, 2014

Dec. 31, 2013

Selling, General and Administrative Expenses [Member]

PDH [Member]

MacDermid [Member]

MacDermid [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

MacDermid Savings Plan [Member]

MacDermid Savings Plan [Member]

PDH [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

Specialty Chemical Business [Member]

Specialty Chemical Business [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

Note 2 - Acquisitions of Businesses (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition, Percentage of Ownership

'

'

'

'

'

'

'

'

'

3.00%

'

3.00%

'

97.00%

'

'

'

Business Combination, Consideration Transferred

'

'

'

'

$8,900,000

'

'

'

'

'

'

'

'

$1,800,000,000

'

'

'

Business Combination, Consideration Transferred, Liabilities Incurred

'

'

'

'

'

'

'

'

'

'

'

'

'

754,200,000

'

'

'

Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000,000

'

'

'

Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred

'

'

'

'

'

'

'

'

'

'

'

'

8,540,000

'

'

'

'

Fair Value Inputs, Discount Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

2.00%

'

'

'

Fair Value Inputs, Future Value of Cash Payments

'

'

'

'

'

'

'

'

'

'

'

'

'

60,000,000

'

'

'

Business Combination, Contingent Consideration, Liability

47,800,000

34,800,000

'

'

'

'

47,800,000

34,800,000

'

'

'

'

'

35,500,000

'

'

35,500,000

Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability

'

'

13,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners

'

'

'

6.76%

'

'

'

'

'

'

'

'

'

'

'

6.76%

'

Annual Maximum Percentage of Holdings Exchanged

'

'

'

'

'

'

'

'

'

'

25.00%

'

'

'

'

'

'

Common Stock, Capital Shares Reserved for Future Issuance (in Shares)

'

'

'

8,900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

20,972,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

20,972,000

Payments to Acquire Businesses, Gross

'

'

'

'

'

$1,114,000

'

'

$2,600,000

'

'

'

'

'

$2,600,000

'

'

Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in Shares)

'

'

'

'

'

'

'

'

1,670,386

'

'

'

'

'

1,670,386

'

'

Business Acquisition, Percentage of Voting Interests Acquired

'

'

'

'

95.00%

'

'

'

'

'

'

3.00%

'

'

3.00%

'

'

Note_2_Acquisitions_of_Busines3

Note 2 - Acquisitions of Businesses (Details) - Preliminary Purchase Price Allocation for Businesses Acquired (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Oct. 31, 2013
In Thousands, unless otherwise specified			MacDermid [Member]	MacDermid [Member]	MacDermid [Member]	MacDermid [Member]	MacDermid [Member]
			Customer Relationships [Member]	Developed Technology Rights [Member]	Trade Names [Member]
Note 2 - Acquisitions of Businesses (Details) - Preliminary Purchase Price Allocation for Businesses Acquired [Line Items]	'	'	'	'	'	'	'
Accounts receivable	'	'	'	'	'	$147,400	'
Inventories	'	'	'	'	'	115,300	'
Other current assets	'	'	'	'	'	26,200	'
Property, plant and equipment	'	'	'	'	'	142,800	'
Intangible assets	'	'	458,400	155,000	73,400	'	'
Goodwill	1,001,748	1,002,886	'	'	'	993,800	'
Other assets	'	'	'	'	'	30,800	'
Accounts payable	'	'	'	'	'	-55,900	'
Other current liabilities	'	'	'	'	'	-62,100	'
Long-term debt	'	'	'	'	'	-754,200	'
Non-current deferred tax liability	'	'	'	'	'	-140,700	'
Contingent consideration	-47,800	-34,800	'	'	'	-35,500	-35,500
Redeemable 401(k) plan interest	'	-20,972	'	'	'	-20,972	'
Other liabilities	'	'	'	'	'	-66,500	'
Total purchase price	'	'	'	'	'	$1,007,200	'

Note_3_Inventories_Details

Note 3 - Inventories (Details) (Fair Value Adjustment to Inventory [Member], USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014
Fair Value Adjustment to Inventory [Member]	'	'	'
Note 3 - Inventories (Details) [Line Items]	'	'	'
Assets, Fair Value Adjustment	$11,956	$23,992	$35,868

Note_3_Inventories_Details_Com

Note 3 - Inventories (Details) - Components of Inventory (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Components of Inventory [Abstract]	'	'
Finished goods	$48,072	$58,360
Raw materials and supplies	29,736	29,870
Equipment	2,062	1,388
Total inventory, net	$79,870	$89,618

Note_4_Property_Plant_and_Equi2

Note 4 - Property, Plant and Equipment (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'	'
Depreciation	$3,573	$3,152

Note_4_Property_Plant_and_Equi3

Note 4 - Property, Plant and Equipment (Details) - Components of Property, Plant and Equipment (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment	$134,335	$135,839
Less: accumulated depreciation	-7,473	-3,900
Property, Plant and Equipment - Net Depreciation	135,743	139,670
Construction in process	8,881	7,731
Land and Land Improvements [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment	29,848	31,246
Building and Building Improvements [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment	39,969	41,118
Machinery and Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment	64,518	63,475
Excluding Construction in Process [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment - Net Depreciation	$126,862	$131,939

Note_5_Goodwill_and_Intangible2

Note 5 - Goodwill and Intangible Assets (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]	'	'
Indefinite-Lived Trade Names (in Dollars)	$73,400	$73,400
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	'15 years	'
Amortization of Intangible Assets (in Dollars)	$13,317	$6,735
Customer Relationships [Member]	'	'
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]	'	'
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	'16 years	'
Developed Technology Rights [Member]	'	'
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]	'	'
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	'10 years	'
Minimum [Member] | Customer Relationships [Member]	'	'
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]	'	'
Finite-Lived Intangible Asset, Useful Life	'8 years	'
Minimum [Member] | Developed Technology Rights [Member]	'	'
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]	'	'
Finite-Lived Intangible Asset, Useful Life	'7 years	'
Maximum [Member] | Customer Relationships [Member]	'	'
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]	'	'
Finite-Lived Intangible Asset, Useful Life	'20 years	'
Maximum [Member] | Developed Technology Rights [Member]	'	'
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]	'	'
Finite-Lived Intangible Asset, Useful Life	'10 years	'

Note_5_Goodwill_and_Intangible3

Note 5 - Goodwill and Intangible Assets (Details) - Changes in the Carrying Amount of Goodwill by Segment (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
		Performance Materials [Member]	Graphic Solutions [Member]	Graphic Solutions [Member]
Goodwill [Line Items]	'	'	'	'
Goodwill Balance	$1,002,886	$773,713	$228,711	$229,173
Acquisition adjustments	3,453	3,453	'	'
Foreign currency translation and other	-4,591	-4,129	-462	'
Goodwill Balance	$1,001,748	$773,037	$228,711	$229,173

Note_5_Goodwill_and_Intangible4

Note 5 - Goodwill and Intangible Assets (Details) - Intangible Assets Subject to Amortization (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	$613,400	$613,400
Accumulated Amortization and Foreign Exchange	-21,223	-3,796
Net Book Value	592,177	609,604
Customer Lists [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	458,400	458,400
Accumulated Amortization and Foreign Exchange	-14,992	-2,290
Net Book Value	443,408	456,110
Developed Technology Rights [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	155,000	155,000
Accumulated Amortization and Foreign Exchange	-6,231	-1,506
Net Book Value	$148,769	$153,494

Note_6_Equity_Compensation_Pla1

Note 6 - Equity Compensation Plans (Details) (USD $)

1 Months Ended

3 Months Ended

1 Months Ended

3 Months Ended

1 Months Ended

3 Months Ended

1 Months Ended

0 Months Ended

3 Months Ended

Jan. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Apr. 30, 2007

Feb. 28, 2011

30-May-08

Mar. 31, 2013

Jan. 31, 2013

30-May-08

30-May-08

Jan. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Apr. 30, 2007

Apr. 30, 2007

Apr. 30, 2007

Dec. 31, 2013

Mar. 06, 2014

Mar. 31, 2014

Per Tranch [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Class A Junior Shares [Member]

Class B Junior Shares [Member]

MacDermid [Member]

The 2013 Plan [Member]

Employee Stock Purchase Plan [Member]

Employee Stock Purchase Plan [Member]

Restricted Stock [Member]

The 2013 Plan [Member]

The 2013 Plan [Member]

The 2013 Plan [Member]

Class A Junior Shares [Member]

Class B Junior Shares [Member]

Class B Junior Shares [Member]

Class B Junior Shares [Member]

Class B Junior Shares [Member]

Class B Junior Shares [Member]

Class B Junior Shares [Member]

Class C Junior Shares [Member]

Class C Junior Shares [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

Class B Junior Shares [Member]

Director [Member]

Maximum [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

Maximum [Member]

Minimum [Member]

Note 6 - Equity Compensation Plans (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

15,500,000

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

1,666,666

9,242

329,823

'

2,150,000

'

1,364,000

'

'

'

'

5,000,000

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options (in Dollars)

'

'

'

$7,100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Allocated Share-based Compensation Expense (in Dollars)

'

'

0

'

'

'

'

36,000

'

'

'

'

'

3,000

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,620,000

'

'

5,178,815

'

Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

Stock Issued During Period, Value, Other (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7,000,000

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

'

'

'

'

'5 years

'

'

'

'

'4 years

'1 year

'

'

'

'

'

'

'

'

'

Potential Value of Shares (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)

'

'

'

'

$1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Intrinsic Value, Amount Per Share (in Dollars per share)

'

'

'

'

'

$0.67

'

'

'

'

'

'

'

$0

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

'

'

'

'

'

'

'

20.00%

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number

1,630,000

'

'

'

'

'

'

'

4,890,000

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Estimated Fair Value (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

$9,030

'

'

'

'

'

'

'

Note_7_Pension_PostRetirement_2

Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Components of Net Periodic Pension and Postretirement Benefit Costs (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Domestic [Member] | Pension and SERP Benefits [Member]	'	'
Net periodic cost (benefit):	'	'
Service cost	'	$1,078
Interest cost on the projected benefit obligation	1,728	1,565
Expected return on plan assets	-2,433	-2,005
Amortization of prior service cost	'	23
Amortization of net loss	'	505
Net periodic (benefit) cost	-705	1,166
Domestic [Member] | Other Postretirement Benefit Plan, Defined Benefit [Member]	'	'
Net periodic cost (benefit):	'	'
Service cost	14	18
Interest cost on the projected benefit obligation	83	73
Amortization of prior service cost	'	-35
Net periodic (benefit) cost	97	56
Foreign [Member] | Pension and SERP Benefits [Member]	'	'
Net periodic cost (benefit):	'	'
Service cost	208	174
Interest cost on the projected benefit obligation	755	768
Expected return on plan assets	-898	-1,283
Amortization of net loss	'	135
Net periodic (benefit) cost	65	-206
Foreign [Member] | Other Postretirement Benefit Plan, Defined Benefit [Member]	'	'
Net periodic cost (benefit):	'	'
Service cost	7	11
Interest cost on the projected benefit obligation	8	10
Amortization of prior service cost	'	7
Net periodic (benefit) cost	$15	$28

Note_8_Debt_Details

Note 8 - Debt (Details) (USD $)

0 Months Ended

3 Months Ended

12 Months Ended

1 Months Ended

0 Months Ended

3 Months Ended

12 Months Ended

0 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

0 Months Ended

1 Months Ended

3 Months Ended

3 Months Ended

3 Months Ended

In Thousands, unless otherwise specified

Jun. 07, 2013

Mar. 31, 2014

Dec. 31, 2013

Oct. 31, 2013

Jun. 07, 2013

Jun. 07, 2013

Jun. 07, 2013

Jun. 07, 2013

Jun. 07, 2013

Jun. 07, 2013

Mar. 31, 2014

Dec. 31, 2013

Jun. 07, 2013

Apr. 12, 2007

Mar. 31, 2013

Oct. 31, 2009

Sep. 30, 2007

31-May-07

Feb. 28, 2007

Jun. 07, 2013

Jun. 07, 2013

Mar. 31, 2014

Oct. 31, 2013

Jun. 07, 2013

Oct. 31, 2013

Mar. 31, 2014

Oct. 31, 2013

Apr. 12, 2007

Mar. 31, 2013

Apr. 12, 2007

Mar. 31, 2013

Apr. 12, 2007

Mar. 31, 2013

Mar. 31, 2014

Apr. 12, 2007

Mar. 31, 2014

Mar. 31, 2014

Early Termination Fees [Member]

Multi-currency [Member]

Subordinated Debt [Member]

Subordinated Debt [Member]

Redemption Premium [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

Senior Subordinated Notes [Member]

Senior Subordinated Notes [Member]

Secured Debt [Member]

Secured Debt [Member]

Secured Debt [Member]

Secured Debt [Member]

Secured Debt [Member]

First Lien Term Loan [Member]

First Lien Term Loan [Member]

First Lien Term Loan [Member]

First Lien Term Loan [Member]

Second Lien Term Loan [Member]

Second Lien Term Loan [Member]

First Lien Facilities [Member]

First Lien Facilities [Member]

First Lien Facilities [Member]

Tranche B Term Loan [Member]

Tranche B Term Loan [Member]

Tranche C Term Loan [Member]

Tranche C Term Loan [Member]

Predecessor Retired Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Minimum [Member]

Maximum [Member]

Second Lien Term Loan [Member]

First Lien Term Loan [Member]

Redemption Premium [Member]

Senior Subordinated Notes [Member]

Senior Subordinated Notes [Member]

First Lien Term Loan [Member]

Second Lien Term Loan [Member]

Predecessor Senior Subordinated Notes [Member]

Predecessor Senior Subordinated Notes [Member]

Japanese Senior Secured Bank Debt [Member]

Japanese Senior Secured Bank Debt [Member]

Japanese Senior Secured Bank Debt [Member]

Japanese Senior Secured Bank Debt [Member]

Japanese Senior Secured Bank Debt [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Overdraft Facility [Member]

Overdraft Facility [Member]

Revolving Credit Facility [Member]

Senior Subordinated Notes [Member]

Predecessor Senior Subordinated Notes [Member]

Predecessor Senior Subordinated Notes [Member]

Predecessor Senior Subordinated Notes [Member]

Note 8 - Debt (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term Debt

'

$749,338

$751,225

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$805,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Face Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,569

2,519

7,557

15,000

'

755,000

'

'

360,000

'

'

'

'

'

360,000

'

250,000

'

'

'

'

'

Line of Credit Facility, Maximum Borrowing Capacity

'

'

'

'

25,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25,000

'

'

'

'

'

'

50,000

50,000

'

'

'

'

'

'

50,000

'

'

Debt Instrument, Interest Rate, Stated Percentage

'

4.00%

4.00%

'

'

'

'

'

'

'

'

'

'

9.50%

'

'

'

'

'

'

4.00%

'

'

7.75%

'

'

'

'

'

'

'

'

'

'

'

1.00%

6.25%

Debt Instrument, Basis Spread on Variable Rate

'

'

'

'

'

'

'

'

3.00%

6.75%

3.00%

3.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Periodic Payment, Principal

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,120

'

'

'

'

'

1,888

1,888

'

'

'

'

'

'

900

'

647

'

'

'

'

'

'

Debt Instrument, Maturity Date

'

31-Dec-20

31-Dec-20

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7-Jun-18

7-Jun-20

'

'

7-Dec-20

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Unamortized Discount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,887

'

1,775

3,600

'

'

'

'

'

'

'

'

'

'

'

'

'

Guaranteed Credit Facilities, Stock of the Company's First Tier Foreign Subsidiaries, Percentage

65.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repayments of Long-term Debt

'

'

'

13,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

373,000

'

'

'

10,277

'

6,810

'

'

'

'

'

'

Debt Instrument, Periodic Payment, Interest

'

'

'

'

'

'

'

'

'

'

'

'

'

'

27

'

'

'

'

'

'

7,512

'

'

'

'

'

'

1,158

'

824

'

'

'

'

'

'

Letters of Credit Outstanding, Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,774

'

'

'

'

'

'

'

'

'

'

'

Revenues and Gains, Reporting Currency Denominated, Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,823

'

'

'

'

'

'

Line of Credit Facility, Commitment Fee Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

57

'

'

'

'

Senior Notes

'

'

'

'

'

'

'

'

'

'

'

'

'

350,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Early Repayment of Senior Debt

'

'

'

'

'

'

100,481

'

'

'

'

'

249,519

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repayments of Senior Debt

'

'

'

'

'

3,182

'

9,357

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Issuance of Senior Long-term Debt

'

'

'

'

'

'

'

'

'

'

'

'

105,864

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest Expense, Debt

'

'

'

'

'

'

'

'

'

'

'

'

2,201

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Minimum Amount Outstanding Subject to Covenant Terms

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

12,500

'

'

'

Short-term Debt

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Overdraft Facility, Maximum Capacity

'

$20,529

$22,075

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Note_8_Debt_Details_Current_an

Note 8 - Debt (Details) - Current and Long-Term Debt (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Note 8 - Debt (Details) - Current and Long-Term Debt [Line Items]	'	'
First lien secured credit facility, due 2020, interest at the greater of 4.00% or LIBOR plus 3.00%, weighted average interest rate of 4.00% at March 31, 2014	$749,338	$751,225
Other	900	1,024
Total debt	750,238	752,249
Less: current portion debt	-7,911	-7,958
Total long-term debt	$742,327	$744,291

Note_8_Debt_Details_Current_an1

Note 8 - Debt (Details) - Current and Long-Term Debt (Parentheticals)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Note 8 - Debt (Details) - Current and Long-Term Debt (Parentheticals) [Line Items]	'	'
Due	31-Dec-20	31-Dec-20
Interest rate	4.00%	4.00%
London Interbank Offered Rate (LIBOR) [Member]	'	'
Note 8 - Debt (Details) - Current and Long-Term Debt (Parentheticals) [Line Items]	'	'
Interest LIBOR plus	3.00%	3.00%
Weighted Average [Member]	'	'
Note 8 - Debt (Details) - Current and Long-Term Debt (Parentheticals) [Line Items]	'	'
Weighted Average Interest Rate	4.00%	'

Note_9_Derivative_Instruments_1

Note 9 - Derivative Instruments (Details)	3 Months Ended			3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2013
	USD ($)	USD ($)	GBP (£)	Foreign Exchange Contract [Member]	Foreign Exchange Contract [Member]
				USD ($)	USD ($)
Note 9 - Derivative Instruments (Details) [Line Items]	'	'	'	'	'
Revenues Denominated in U.S. Dollars, Percentage	25.00%	'	'	'	'
Foreign Currency Cash Flow Hedge Asset at Fair Value	$5,000	'	£ 3,107	$5,000	'
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax	4	-507	'	15	780
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	'	'	'	$159	$223

Note_9_Derivative_Instruments_2

Note 9 - Derivative Instruments (Details) - Foreign Currency Forward Contract Derivative Instrument Amounts	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2014
	USD ($)	GBP (£)
Derivative Assets	'	'
Great Britain Pound	$5,000	£ 3,107
Great Britain Pound	100.00%	100.00%
Great Britain Pound	30-Jun-14	30-Jun-14

Note_9_Derivative_Instruments_3

Note 9 - Derivative Instruments (Details) - Fair Value of Derivative Instruments Reported in the Balance Sheets (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Derivatives, Fair Value [Line Items]	'	'
Foreign exchange contracts	$178	$163
Designated as Hedging Instrument [Member] | Other Current Assets [Member] | Foreign Exchange Contract [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Foreign exchange contracts	$178	$163

Note_10_Fair_Value_Measurement2

Note 10 - Fair Value Measurements (Details) (USD $)	Mar. 31, 2014
Fair Value Disclosures [Abstract]	'
Investment Net Asset Value	$1

Note_10_Fair_Value_Measurement3

Note 10 - Fair Value Measurements (Details) - Financial Instruments, Assets and Liabilities Measured at Fair Value (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Note 10 - Fair Value Measurements (Details) - Financial Instruments, Assets and Liabilities Measured at Fair Value [Line Items]	'	'
Money market accounts	$80,621	$78,633
Available for sale equity securities	2,264	2,302
Derivatives	178	163
Total	83,063	81,098
Long term contingent consideration	47,800	34,800
Fair Value, Inputs, Level 1 [Member]	'	'
Note 10 - Fair Value Measurements (Details) - Financial Instruments, Assets and Liabilities Measured at Fair Value [Line Items]	'	'
Money market accounts	80,621	78,633
Available for sale equity securities	1,399	1,470
Total	82,020	80,103
Fair Value, Inputs, Level 2 [Member]	'	'
Note 10 - Fair Value Measurements (Details) - Financial Instruments, Assets and Liabilities Measured at Fair Value [Line Items]	'	'
Available for sale equity securities	865	832
Derivatives	178	163
Total	1,043	995
Fair Value, Inputs, Level 3 [Member]	'	'
Note 10 - Fair Value Measurements (Details) - Financial Instruments, Assets and Liabilities Measured at Fair Value [Line Items]	'	'
Long term contingent consideration	$47,800	$34,800

Note_10_Fair_Value_Measurement4

Note 10 - Fair Value Measurements (Details) - Carrying Value and Estimated Fair Value of the Companybs First Lien Loan (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Carrying Value and Estimated Fair Value of the Companybs First Lien Loan [Abstract]	'	'
First lien credit facility, including current portion	$749,338	$751,225
First lien credit facility, including current portion	$750,649	$752,637

Note_11_Stockholders_Equity_De

Note 11 - Stockholders' Equity (Details) (USD $)

1 Months Ended

3 Months Ended

0 Months Ended

1 Months Ended

1 Months Ended

3 Months Ended

1 Months Ended

1 Months Ended

2 Months Ended

3 Months Ended

22-May-13

Mar. 31, 2014

Mar. 04, 2014

Jan. 23, 2014

Dec. 31, 2013

Apr. 03, 2014

Apr. 30, 2014

22-May-13

22-May-13

Mar. 31, 2014

22-May-13

Mar. 31, 2014

Mar. 31, 2014

Mar. 04, 2014

22-May-13

22-May-13

Apr. 25, 2013

22-May-13

22-May-13

Mar. 04, 2014

Mar. 31, 2014

Subsequent Event [Member]

Subsequent Event [Member]

Warrants and Rights Subject to Mandatory Redemption [Member]

Warrant Exchange Offer [Member]

Criteria [Member]

Criteria [Member]

IPO [Member]

Warrant [Member]

Warrant [Member]

Warrant [Member]

Founders [Member]

Founders [Member]

Non-founder Directors [Member]

Two Independent Directors [Member]

MacDermid [Member]

MacDermid [Member]

Warrant [Member]

Note 11 - Stockholders' Equity (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Shares Issued

2,000,000

2,000,000

'

'

2,000,000

'

'

'

'

'

'

'

'

'

'

1,999,998

2

'

'

'

'

Preferred Stock, Value, Issued (in Dollars)

'

$20,000

'

'

'

'

'

'

'

'

'

'

'

'

'

$20,000,000

$20,000

'

'

'

'

Share Price (in Dollars per share)

'

'

'

$0.01

'

'

'

'

'

$11.50

$18

$10

'

'

'

$10.50

'

$10

$10.50

'

'

Preferred Stock, Stock Dividend, Threshold Consecutive Trading Days

'

'10 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Ordinary Share Market Price Appreciation Dividend Percentage

'

20.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares, Issued

'

120,239,236

'

'

103,571,941

'

'

'

'

'

'

90,500,000

'

'

'

'

'

'

'

'

'

Convertible Preferred Stock, Shares Issued upon Conversion

'

1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

88,500,000

14,996,909

'

'

'

'

1,251,744

'

13,462,280

'

'

'

'

'

'

380,952

'

29,500

190,476

'

'

Proceeds from Issuance Initial Public Offering (in Dollars)

885,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Outstanding

'

3,763,812

'

'

'

'

'

90,529,500

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

11.5

'

'

'

'

'

'

Class of Warrant or Right, Exercisable Time Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'3 years

'

'

'

'

'

'

Class of Warrant or Right, Warrant Redemption Price (in Dollars)

'

'

'

'

'

0.01

'

'

'

'

'

'

'

0.01

0.01

'

'

'

'

'

'

Class of Warrant or Right, Threshold Consecutive Trading Days

'10 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition, Percentage of Voting Interests Acquired

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.00%

'

Payments to Acquire Businesses, Gross (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,600,000

'

Business Acquisition, Equity Interest Issued or Issuable, Number of Shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,670,386

'

Common Stock, Shares Issued Upon Conversion

'

'

1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Par or Stated Value Per Share (in Dollars per share)

'

$0.01

$0.01

'

$0.01

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Series A Preferred Stock Shares Issued Upon Conversion

'

'

1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sale of Stock, Price Per Share (in Dollars per share)

'

'

'

'

'

'

'

'

$10.50

'

'

'

'

'

'

'

'

'

'

'

'

Warrants Exchanged Per Common Share

'

'

'

'

'

'

'

'

3

'

'

'

'

'

'

'

'

'

'

'

'

Warrants Exchanged for Common Stock

'

'

'

'

'

'

3,755,232

'

40,386,840

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Issuance of Common Stock (in Dollars)

'

172,463,000

'

'

'

'

'

'

141,354,000

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Warrant Exercises (in Dollars)

'

'

'

'

'

'

14,395,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Warrants Redeemed

'

'

'

'

'

8,580

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

'

'

'

'

'

'

'

'

'

'

'

'

44,978,850

'

'

'

'

'

'

'

'

Business Acquisition, Equity Interest Issued or Issuable, Value Assigned (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

97,500,000

Annual Amount of Equity of Wholly Owned Subsidiary Eligible to be Exchanged for Common shares of the Company, Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25.00%

Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6.76%

Income (Loss) Attributable to Noncontrolling Interest (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1,314,000

Note_11_Stockholders_Equity_De1

Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity (USD $)	1 Months Ended	3 Months Ended
In Thousands, except Share data, unless otherwise specified	22-May-13	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'	'
Balance, amount	'	$1,304,031	$270,688	$1,128,616	$272,437
Issuance of 3,959 common shares @ $11.00 per share on January 5, 2014 (in Shares)	88,500,000	14,996,909	'	'	'
Issuance of 3,959 common shares @ $11.00 per share on January 5, 2014	'	44	'	'	'
Net (loss) income	'	-5,948	15,337	'	'
Foreign currency translation adjustments	'	-9,281	'	'	'
Pension and postretirement plans, tax benefit of $11	'	11	'	'	'
Derivatives valuation, net of tax expense of $11	'	4	-507	'	'
Unrealized gain on available for sale equity securities, net of tax benefit of $18	'	-34	94	'	'
Dividend paid to non-controlling interest partner	'	-174	-173	'	'
Exchange of Warrants [Member] | Common Stock [Member]	'	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'	'
Exercise of warrants for 14,992,950 common shares @ $11.50 per share (in Shares)	'	14,992,950	'	'	'
Exercise of warrants for 14,992,950 common shares @ $11.50 per share	'	150	'	'	'
Exchange of Warrants [Member] | Additional Paid-in Capital [Member]	'	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'	'
Exercise of warrants for 14,992,950 common shares @ $11.50 per share	'	172,269	'	'	'
Exchange of Warrants [Member] | Parent [Member]	'	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'	'
Exercise of warrants for 14,992,950 common shares @ $11.50 per share	'	172,419	'	'	'
Exchange of Warrants [Member]	'	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'	'
Exercise of warrants for 14,992,950 common shares @ $11.50 per share	'	172,419	'	'	'
Preferred Stock [Member]	'	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'	'
Balance, shares (in Shares)	'	2,000,000	'	2,000,000	'
Balance, amount	'	20	'	'	'
Impact of Domestication	'	20	'	'	'
Common Stock [Member] | United States Postretirement Benefit Plan of US Entity, Defined Benefit [Member]	'	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'	'
Issuance of 1,670,386 common shares @$11.00 per share in connection with 401(k) Exchange Agreement (in Shares)	'	1,670,386	'	'	'
Issuance of 1,670,386 common shares @$11.00 per share in connection with 401(k) Exchange Agreement	'	16	'	'	'
Common Stock [Member]	'	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'	'
Balance, shares (in Shares)	'	120,239,236	'	103,571,941	'
Balance, amount	'	1,182	50,000	'	50,000
Impact of Domestication	'	1,016	'	'	'
Issuance of 3,959 common shares @ $11.00 per share on January 5, 2014 (in Shares)	'	3,959	'	'	'
Additional Paid-in Capital [Member] | United States Postretirement Benefit Plan of US Entity, Defined Benefit [Member]	'	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'	'
Issuance of 1,670,386 common shares @$11.00 per share in connection with 401(k) Exchange Agreement	'	18,358	'	'	'
Additional Paid-in Capital [Member]	'	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'	'
Balance, amount	'	1,401,673	2,357	1,212,038	2,318
Impact of Domestication	'	-1,036	'	'	'
Issuance of 3,959 common shares @ $11.00 per share on January 5, 2014	'	44	'	'	'
Retained Earnings [Member]	'	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'	'
Balance, amount	'	-201,639	-269,632	-194,222	-273,086
Net (loss) income	'	-7,417	15,248	'	'
Accumulated Other Comprehensive Income (Loss) [Member]	'	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'	'
Balance, amount	'	5,484	-47,207	14,779	-30,270
Foreign currency translation adjustments	'	-9,276	'	'	'
Pension and postretirement plans, tax benefit of $11	'	11	'	'	'
Derivatives valuation, net of tax expense of $11	'	4	-507	'	'
Unrealized gain on available for sale equity securities, net of tax benefit of $18	'	-34	94	'	'
Parent [Member] | United States Postretirement Benefit Plan of US Entity, Defined Benefit [Member]	'	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'	'
Issuance of 1,670,386 common shares @$11.00 per share in connection with 401(k) Exchange Agreement	'	18,374	'	'	'
Parent [Member]	'	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'	'
Balance, amount	'	1,206,720	271,075	1,032,595	272,725
Issuance of 3,959 common shares @ $11.00 per share on January 5, 2014	'	44	'	'	'
Net (loss) income	'	-7,417	15,248	'	'
Foreign currency translation adjustments	'	-9,276	'	'	'
Pension and postretirement plans, tax benefit of $11	'	11	'	'	'
Derivatives valuation, net of tax expense of $11	'	4	-507	'	'
Unrealized gain on available for sale equity securities, net of tax benefit of $18	'	-34	94	'	'
Noncontrolling Interest [Member]	'	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'	'
Balance, amount	'	97,311	-387	96,021	-288
Net (loss) income	'	1,469	89	'	'
Foreign currency translation adjustments	'	-5	'	'	'
Dividend paid to non-controlling interest partner	'	-174	-173	'	'
United States Postretirement Benefit Plan of US Entity, Defined Benefit [Member]	'	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'	'
Issuance of 1,670,386 common shares @$11.00 per share in connection with 401(k) Exchange Agreement	'	$18,374	'	'	'

Note_11_Stockholders_Equity_De2

Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity (Parentheticals) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Exchange of Warrants [Member] | Additional Paid-in Capital [Member]	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity (Parentheticals) [Line Items]	'	'
Issuance of common shares, per share	$11.50	'
Additional Paid-in Capital [Member] | United States Postretirement Benefit Plan of US Entity, Defined Benefit [Member]	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity (Parentheticals) [Line Items]	'	'
Issuance of common shares, per share	$11	'
Additional Paid-in Capital [Member]	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity (Parentheticals) [Line Items]	'	'
Issuance of common shares, per share	$11	'
Retained Earnings [Member]	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity (Parentheticals) [Line Items]	'	'
Pension and postretirement plans, tax benefit	$11	'
Derivatives valuation, tax expense	11	'
Unrealized gain on available for sale equity securities, tax benefit	$18	$51

Note_11_Stockholders_Equity_De3

Note 11 - Stockholders' Equity (Details) - Predecessor Reconciliation of Consolidated Changes in Equity (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
Note 11 - Stockholders' Equity (Details) - Predecessor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'
Balance	$1,304,031	$270,688	$1,128,616	$272,437
Net income	-5,948	15,337	'	'
Equity compensation (in Shares)	'	39	'	'
Accrual of paid in kind dividend on cumulative preferred shares	'	-11,794	'	'
Foreign currency translation adjustments	'	-16,556	'	'
Derivatives valuation, net of tax benefit of $273	4	-507	'	'
Unrealized loss on available for sale equity securities, net of tax expense of $51	-34	94	'	'
Dividend paid to non-controlling interest partner	-174	-173	'	'
Contribution from non-controlling interest	'	17	'	'
Preferred Stock [Member] | Series A Preferred Stock [Member]	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Predecessor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'
Balance	'	536,821	'	525,027
Accrual of paid in kind dividend on cumulative preferred shares	'	11,794	'	'
Preferred Stock [Member]	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Predecessor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'
Balance	20	'	'	'
Common Stock [Member]	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Predecessor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'
Balance	1,182	50,000	'	50,000
Additional Paid-in Capital [Member]	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Predecessor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'
Balance	1,401,673	2,357	1,212,038	2,318
Equity compensation (in Shares)	'	39	'	'
Retained Earnings [Member]	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Predecessor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'
Balance	-201,639	-269,632	-194,222	-273,086
Net income	-7,417	15,248	'	'
Accrual of paid in kind dividend on cumulative preferred shares	'	-11,794	'	'
Accumulated Other Comprehensive Income (Loss) [Member]	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Predecessor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'
Balance	5,484	-47,207	14,779	-30,270
Foreign currency translation adjustments	'	-16,524	'	'
Derivatives valuation, net of tax benefit of $273	4	-507	'	'
Unrealized loss on available for sale equity securities, net of tax expense of $51	-34	94	'	'
Treasury Stock [Member]	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Predecessor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'
Balance	'	-1,264	'	-1,264
Parent [Member]	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Predecessor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'
Balance	1,206,720	271,075	1,032,595	272,725
Net income	-7,417	15,248	'	'
Equity compensation (in Shares)	'	39	'	'
Foreign currency translation adjustments	'	-16,524	'	'
Derivatives valuation, net of tax benefit of $273	4	-507	'	'
Unrealized loss on available for sale equity securities, net of tax expense of $51	-34	94	'	'
Noncontrolling Interest [Member]	'	'	'	'
Note 11 - Stockholders' Equity (Details) - Predecessor Reconciliation of Consolidated Changes in Equity [Line Items]	'	'	'	'
Balance	97,311	-387	96,021	-288
Net income	1,469	89	'	'
Foreign currency translation adjustments	'	-32	'	'
Dividend paid to non-controlling interest partner	-174	-173	'	'
Contribution from non-controlling interest	'	$17	'	'

Note_11_Stockholders_Equity_De4

Note 11 - Stockholders' Equity (Details) - Predecessor Reconciliation of Consolidated Changes in Equity (Parentheticals) (Retained Earnings [Member], USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Retained Earnings [Member]	'	'
Note 11 - Stockholders' Equity (Details) - Predecessor Reconciliation of Consolidated Changes in Equity (Parentheticals) [Line Items]	'	'
Tax benefit	'	$273
Tax expense	$18	$51

Note_12_Earnings_Per_Share_Det

Note 12 - Earnings Per Share (Details)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014
Warrant [Member]	'
Note 12 - Earnings Per Share (Details) [Line Items]	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	4.5
Equity Option [Member]	'
Note 12 - Earnings Per Share (Details) [Line Items]	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0.1
Stock Compensation Plan [Member]	'
Note 12 - Earnings Per Share (Details) [Line Items]	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0.5
Contingently Issuable Shares for the Founder Preferred Share Dividend Right [Member]	'
Note 12 - Earnings Per Share (Details) [Line Items]	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	8.8
Shares Issuable Upon Conversion of PDH Non-controlling Interest [Member]	'
Note 12 - Earnings Per Share (Details) [Line Items]	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	8.8
Shares Issuable Upon Conversion of Founder Preferred Shares [Member]	'
Note 12 - Earnings Per Share (Details) [Line Items]	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2
Shares Issuable Upon Conversion of 401k Exchange Rights [Member]	'
Note 12 - Earnings Per Share (Details) [Line Items]	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1.1

Note_12_Earnings_Per_Share_Det1

Note 12 - Earnings Per Share (Details) - Weighted Average Shares Outstanding	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014		Mar. 31, 2013
Weighted Average Shares Outstanding [Abstract]	'		'
Basic	107,160		'
Convertible securities	'	[1]	'
Diluted	107,160		'
[1]	No share adjustments are included in the dilutive weighted average shares outstanding computation as the three months ended March 31, 2014 resulted in a net loss.

Note_13_Contingencies_Environm1

Note 13 - Contingencies, Environmental and Legal Matters (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Commitments and Contingencies Disclosure [Abstract]	'	'
Asset Retirement Obligation	$4,864	$4,765
Reserves for Environmental Contingencies	2,816	2,896
Loss Contingency, Estimate of Possible Loss	$3,708	$2,881

Note_15_Related_Party_Transact1

Note 15 - Related Party Transactions (Details) (USD $)	Mar. 31, 2014	Oct. 31, 2013	Oct. 31, 2013	Oct. 31, 2014	Nov. 07, 2013	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Oct. 31, 2013
	Seven-Year Period [Member]	Annual Fee [Member]	Mariposa Capital [Member]	Mariposa Capital [Member]	Pershing Square [Member]	Court Square [Member]	Weston Presidio [Member]	MacDermid [Member]	MacDermid [Member]
	Maximum [Member]	Mariposa Capital [Member]
	MacDermid [Member]
Note 15 - Related Party Transactions (Details) [Line Items]	'	'	'	'	'	'	'	'	'
Business Acquisition, Shares Price Exchange Rate	'	'	'	'	'	'	'	$11	'
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High	100,000,000	'	'	'	'	'	'	'	100,000,000
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners	'	'	'	'	'	'	'	6.76%	'
Related Party Transaction, Amounts of Transaction	'	2,000,000	'	'	'	'	'	'	'
Related Party, Agreement Renewal Term	'	'	'1 year	'	'	'	'	'	'
Related Party, Notice of Non-Renewal to Agreement	'	'	'90 days	'	'	'	'	'	'
Related Party, Effective Termination Date After Expiration of Agreement Term	'	'	'6 months	'	'	'	'	'	'
Professional Fees	'	'	'	500,000	'	'	'	'	'
Related Party, Ownership Percentage	'	'	'	'	31.00%	'	'	'	'
Management Fee Expense	'	'	'	'	'	$102,000	$23,000	'	'

Note_16_Restructuring_Activiti2

Note 16 - Restructuring Activities (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Restructuring and Related Activities [Abstract]	'	'
Restructuring Charges	$0	$1,606
Restructuring Reserve, Current	$1,311	'

Note_16_Restructuring_Activiti3

Note 16 - Restructuring Activities (Details) - Activity in Restructuring Liabilities (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Balance - Restructuring Liability	$1,311	$2,077	$2,029	$632
Charges to Expense	0	1,606	'	'
Cash Payments	-718	-142	'	'
Non-cash Adjustments	'	-19	'	'
Total Costs and Adjustments	-718	1,445	'	'
Graphic Solutions [Member] | Severance and Other Benefits [Member]	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Balance - Restructuring Liability	497	1,447	699	'
Charges to Expense	'	1,504	'	'
Cash Payments	-202	-57	'	'
Total Costs and Adjustments	-202	1,447	'	'
Graphic Solutions [Member]	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Balance - Restructuring Liability	497	1,447	699	'
Charges to Expense	'	1,504	'	'
Cash Payments	-202	-57	'	'
Total Costs and Adjustments	-202	1,447	'	'
Performance Materials [Member] | Severance and Other Benefits [Member]	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Balance - Restructuring Liability	814	630	1,330	632
Charges to Expense	'	102	'	'
Cash Payments	-516	-85	'	'
Non-cash Adjustments	'	-19	'	'
Total Costs and Adjustments	-516	-2	'	'
Performance Materials [Member]	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Balance - Restructuring Liability	814	630	1,330	632
Charges to Expense	'	102	'	'
Cash Payments	-516	-85	'	'
Non-cash Adjustments	'	-19	'	'
Total Costs and Adjustments	($516)	($2)	'	'

Note_17_Segment_Information_De

Note 17 - Segment Information (Details)	3 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
Number of Reportable Segments	2
Number of Major Product Lines	2

Note_17_Segment_Information_De1

Note 17 - Segment Information (Details) - Financial Information Regarding Each Reportable Segment (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Net Sales:	'	'
Net Sales	$183,726	$182,132
Operating (loss) profit:	'	'
Operating Profit (loss)	3,992	29,776
Performance Materials [Member]	'	'
Net Sales:	'	'
Net Sales	143,111	138,824
Operating (loss) profit:	'	'
Operating Profit (loss)	8,839	21,447
Graphic Solutions [Member]	'	'
Net Sales:	'	'
Net Sales	40,615	43,308
Operating (loss) profit:	'	'
Operating Profit (loss)	($4,847)	$8,329

Note_18_Subsequent_Events_Deta

Note 18 - Subsequent Events (Details) (USD $)	3 Months Ended	0 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Apr. 16, 2014	Apr. 16, 2014	Apr. 16, 2014	Apr. 16, 2014
		Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]
		Chemtura [Member]	Chemtura [Member]	First Lien Credit Facility [Member]	Second Lien Facility [Member]
			Cash [Member]
Note 18 - Subsequent Events (Details) [Line Items]	'	'	'	'	'
Number of Major Product Lines	2	7	'	'	'
Business Combination, Consideration Transferred	'	$1,000,000	$950,000	'	'
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in Shares)	'	2,000,000	'	'	'
Line of Credit Facility, Maximum Borrowing Capacity	'	'	'	$600,000	$120,000